Go to the Table of Contents
130401
Table 1.47C – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 479 471 87 107 54 56
GENDER            
Male 376 372 80 102 51 56
Female 252 243 34 34 19 7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 460 447 86 84 54 54
White 465 455 79 76 50 49
Black or African American 99 96 16 20 16 20
American Indian or Alaska Native 25 24 * 7 * *
Native Hawaiian or Other Pacific Islander * 6 * 2 * *
Asian 54 81 19 26 10 6
Two or More Races 61 33 14 9 7 7
Hispanic or Latino 135 154 11 67 4 15
EDUCATION            
< High School 136 148 31 16 29 16
High School Graduate 211 253 32 58 21 6
Some College 251 239 39 36 30 26
College Graduate 338 333 64 80 27 46
CURRENT EMPLOYMENT            
Full-Time 380 384 54 91 38 36
Part-Time 168 178 6 28 * 21
Unemployed 105 121 41 44 11 *
Other1 208 215 53 22 37 8
130401
Table 1.47D – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.24 0.23 0.04 0.05 0.03 0.03
GENDER            
Male 0.40 0.39 0.08 0.11 0.05 0.06
Female 0.24 0.23 0.03 0.03 0.02 0.01
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.27 0.26 0.05 0.05 0.03 0.03
White 0.32 0.31 0.06 0.06 0.04 0.04
Black or African American 0.45 0.43 0.07 0.09 0.07 0.09
American Indian or Alaska Native 2.37 2.30 * 0.69 * *
Native Hawaiian or Other Pacific Islander * 0.81 * 0.28 * *
Asian 0.58 0.82 0.20 0.26 0.11 0.06
Two or More Races 2.28 1.27 0.55 0.33 0.26 0.25
Hispanic or Latino 0.50 0.56 0.04 0.24 0.01 0.05
EDUCATION            
< High School 0.49 0.50 0.11 0.06 0.11 0.05
High School Graduate 0.35 0.42 0.05 0.10 0.04 0.01
Some College 0.48 0.45 0.08 0.07 0.06 0.05
College Graduate 0.51 0.48 0.10 0.13 0.04 0.07
CURRENT EMPLOYMENT            
Full-Time 0.35 0.34 0.05 0.09 0.04 0.03
Part-Time 0.71 0.73 0.02 0.12 * 0.09
Unemployed 1.09 1.19 0.45 0.46 0.12 *
Other1 0.32 0.33 0.08 0.04 0.06 0.01
130401
Table 1.47P – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.2132   0.8477   0.2994  
GENDER            
Male 0.1266   0.7736   0.4520  
Female 0.9590   0.7745   0.2388  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.1586   0.4808   0.2147  
White 0.1311   0.5070   0.2087  
Black or African American 0.6216   0.7344   0.7669  
American Indian or Alaska Native 0.4005   *   *  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.1845   0.6136   0.8475  
Two or More Races 0.0246   0.8257   0.8666  
Hispanic or Latino 0.8020   0.1087   0.3827  
EDUCATION            
< High School 0.6216   0.1542   0.1655  
High School Graduate 0.2472   0.9520   0.1667  
Some College 0.8186   0.7548   0.6467  
College Graduate 0.4562   0.3803   0.7540  
CURRENT EMPLOYMENT            
Full-Time 0.3348   0.3571   0.4193  
Part-Time 0.5783   0.0852   *  
Unemployed 0.5068   0.7941   *  
Other1 0.2753   0.0726   0.0305  
130401
Table 1.48C – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 487 486 99 115 65 62
GENDER            
Male 377 382 86 107 56 59
Female 263 250 45 42 26 17
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 468 458 97 93 64 59
White 475 467 85 83 54 53
Black or African American 103 99 19 24 17 23
American Indian or Alaska Native 26 28 * 7 * *
Native Hawaiian or Other Pacific Islander 23 12 9 2 9 *
Asian 55 82 22 26 14 6
Two or More Races 61 36 15 11 7 8
Hispanic or Latino 139 159 21 69 11 17
EDUCATION            
< High School 140 153 34 26 30 20
High School Graduate 215 256 40 62 23 15
Some College 261 252 55 43 44 28
College Graduate 344 335 65 81 29 47
CURRENT EMPLOYMENT            
Full-Time 384 390 57 94 38 38
Part-Time 175 185 22 37 11 26
Unemployed 112 126 44 45 15 37
Other1 213 217 60 29 45 14
130401
Table 1.48D – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.21 0.21 0.04 0.05 0.03 0.03
GENDER            
Male 0.34 0.34 0.08 0.09 0.05 0.05
Female 0.22 0.21 0.04 0.03 0.02 0.01
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.24 0.23 0.05 0.05 0.03 0.03
White 0.28 0.27 0.05 0.05 0.04 0.03
Black or African American 0.38 0.36 0.07 0.09 0.06 0.08
American Indian or Alaska Native 2.03 1.96 * 0.56 * *
Native Hawaiian or Other Pacific Islander 2.65 1.28 1.03 0.23 1.03 *
Asian 0.49 0.71 0.20 0.23 0.12 0.05
Two or More Races 1.80 1.08 0.44 0.32 0.20 0.24
Hispanic or Latino 0.41 0.46 0.06 0.20 0.03 0.05
EDUCATION            
< High School 0.42 0.44 0.10 0.08 0.09 0.06
High School Graduate 0.30 0.36 0.06 0.09 0.03 0.02
Some College 0.40 0.38 0.09 0.07 0.07 0.04
College Graduate 0.48 0.45 0.10 0.12 0.04 0.07
CURRENT EMPLOYMENT            
Full-Time 0.32 0.31 0.05 0.08 0.03 0.03
Part-Time 0.52 0.53 0.07 0.11 0.04 0.08
Unemployed 0.77 0.86 0.32 0.33 0.11 0.27
Other1 0.29 0.29 0.08 0.04 0.06 0.02
130401
Table 1.48P – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.3673   0.9655   0.2404  
GENDER            
Male 0.1690   0.8744   0.3422  
Female 0.7281   0.6110   0.3802  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.2638   0.4855   0.2163  
White 0.2326   0.5890   0.2291  
Black or African American 0.6724   0.9105   0.9343  
American Indian or Alaska Native 0.3327   *   *  
Native Hawaiian or Other Pacific Islander 0.1426   0.2743   *  
Asian 0.2498   0.7170   0.2120  
Two or More Races 0.0634   0.8170   0.4624  
Hispanic or Latino 0.6509   0.2379   0.8976  
EDUCATION            
< High School 0.8131   0.4023   0.2449  
High School Graduate 0.3316   0.8819   0.4167  
Some College 0.9084   0.2724   0.3548  
College Graduate 0.5935   0.3700   0.8491  
CURRENT EMPLOYMENT            
Full-Time 0.4475   0.2892   0.6410  
Part-Time 0.7616   0.0670   0.0767  
Unemployed 0.3415   0.3387   0.9185  
Other1 0.3243   0.0317   0.0064  
130401
Table 1.49C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 752 765 363 406 231 265
AGE            
12-17 64 64 53 53 35 37
18-25 145 151 110 111 69 74
26 or Older 740 740 338 380 215 247
GENDER            
Male 518 557 250 293 165 181
Female 496 509 242 277 152 173
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 702 711 336 358 207 240
White 634 662 307 329 186 221
Black or African American 208 218 106 143 52 70
American Indian or Alaska Native 51 60 35 39 25 22
Native Hawaiian or Other Pacific Islander * 51 16 12 15 5
Asian 111 142 53 71 38 41
Two or More Races 107 88 33 33 25 17
Hispanic or Latino 258 313 135 186 96 101
130401
Table 1.49D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.29 0.29 0.14 0.16 0.09 0.10
AGE            
12-17 0.26 0.26 0.21 0.21 0.14 0.15
18-25 0.42 0.44 0.32 0.32 0.20 0.21
26 or Older 0.37 0.37 0.17 0.19 0.11 0.12
GENDER            
Male 0.42 0.44 0.20 0.23 0.13 0.14
Female 0.37 0.38 0.18 0.21 0.11 0.13
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.32 0.32 0.15 0.16 0.09 0.11
White 0.37 0.39 0.18 0.19 0.11 0.13
Black or African American 0.69 0.71 0.35 0.46 0.17 0.23
American Indian or Alaska Native 3.19 3.60 2.34 2.52 1.63 1.52
Native Hawaiian or Other Pacific Islander * 4.70 1.75 1.20 1.65 0.48
Asian 0.87 1.05 0.42 0.54 0.30 0.33
Two or More Races 2.31 2.08 0.84 0.83 0.63 0.41
Hispanic or Latino 0.65 0.78 0.34 0.46 0.24 0.25
130401
Table 1.49P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0121   0.0004   0.0593  
AGE            
12-17 0.6854   0.1606   0.9119  
18-25 0.2126   0.0320   0.2813  
26 or Older 0.0206   0.0009   0.0991  
GENDER            
Male 0.0541   0.0178   0.2199  
Female 0.0823   0.0061   0.1207  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.2252   0.0041   0.0779  
White 0.4487   0.0812   0.1828  
Black or African American 0.3787   0.0048   0.0162  
American Indian or Alaska Native 0.4872   0.9189   0.5389  
Native Hawaiian or Other Pacific Islander *   0.6622   0.1417  
Asian 0.0667   0.1767   0.4835  
Two or More Races 0.8160   0.8395   0.2906  
Hispanic or Latino 0.0004   0.0314   0.4722  
130401
Table 1.50C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 64 64 53 53 35 37
GENDER            
Male 46 46 37 38 24 26
Female 46 46 38 38 24 27
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 54 53 45 45 30 31
White 50 51 42 43 24 28
Black or African American 28 26 21 21 13 15
American Indian or Alaska Native 6 5 6 3 4 3
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 13 10 10 7 6 5
Two or More Races 14 13 11 12 8 8
Hispanic or Latino 35 37 28 27 16 19
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 34 34 28 27 17 18
Female, White, Not Hispanic 34 38 30 32 18 21
Male, Black, Not Hispanic 18 18 15 13 8 7
Female, Black, Not Hispanic 20 19 13 17 10 13
Male, Hispanic 25 28 19 23 11 16
Female, Hispanic 27 27 21 19 12 12
130401
Table 1.50D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.26 0.26 0.21 0.21 0.14 0.15
GENDER            
Male 0.36 0.36 0.29 0.29 0.18 0.20
Female 0.37 0.38 0.31 0.31 0.20 0.22
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.28 0.27 0.23 0.23 0.16 0.16
White 0.32 0.32 0.28 0.28 0.17 0.19
Black or African American 0.73 0.70 0.55 0.57 0.37 0.40
American Indian or Alaska Native 3.46 3.01 3.40 1.94 2.83 1.61
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 1.02 0.84 0.80 0.54 0.48 0.38
Two or More Races 1.81 1.66 1.52 1.53 1.07 1.02
Hispanic or Latino 0.65 0.67 0.51 0.50 0.30 0.35
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 0.45 0.45 0.37 0.36 0.23 0.25
Female, White, Not Hispanic 0.46 0.50 0.42 0.44 0.26 0.30
Male, Black, Not Hispanic 0.98 0.96 0.83 0.73 0.46 0.39
Female, Black, Not Hispanic 1.05 1.02 0.70 0.91 0.53 0.69
Male, Hispanic 0.85 0.91 0.67 0.77 0.39 0.57
Female, Hispanic 0.93 0.99 0.76 0.68 0.45 0.44
130401
Table 1.50P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6854   0.1606   0.9119  
GENDER            
Male 0.9545   0.3475   0.8587  
Female 0.6066   0.2918   0.9822  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.7606   0.3062   0.8840  
White 0.7406   0.2646   0.8947  
Black or African American 0.8305   0.5228   0.4228  
American Indian or Alaska Native 0.3860   0.0802   0.3801  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.6021   0.4442   0.8115  
Two or More Races 0.8448   0.7072   0.4481  
Hispanic or Latino 0.7925   0.3215   0.9854  
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 0.5559   0.2640   0.8878  
Female, White, Not Hispanic 0.9021   0.6318   0.9691  
Male, Black, Not Hispanic 0.7435   0.9811   0.9973  
Female, Black, Not Hispanic 0.9880   0.3931   0.3218  
Male, Hispanic 0.8899   0.9037   0.5508  
Female, Hispanic 0.6054   0.1770   0.4880  
130401
Table 1.51C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 145 151 110 111 69 74
GENDER            
Male 104 105 79 84 50 52
Female 99 101 71 72 45 49
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 129 135 98 99 63 67
White 151 168 101 107 61 65
Black or African American 51 55 30 41 17 24
American Indian or Alaska Native 14 * 8 * 4 4
Native Hawaiian or Other Pacific Islander * * * 5 * 4
Asian 31 31 18 23 11 18
Two or More Races 22 30 16 24 12 9
Hispanic or Latino 69 69 46 53 27 31
EDUCATION            
< High School 67 72 46 54 31 28
High School Graduate 99 109 68 78 41 44
Some College 121 125 78 86 46 51
College Graduate 68 66 37 43 23 22
CURRENT EMPLOYMENT            
Full-Time 112 114 70 74 41 48
Part-Time 91 103 61 71 40 39
Unemployed 59 58 44 43 30 32
Other1 79 92 55 68 34 31
130401
Table 1.51D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.42 0.44 0.32 0.32 0.20 0.21
GENDER            
Male 0.61 0.60 0.46 0.48 0.29 0.30
Female 0.58 0.59 0.42 0.42 0.26 0.28
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.47 0.49 0.36 0.36 0.23 0.24
White 0.56 0.57 0.43 0.43 0.28 0.30
Black or African American 0.92 0.99 0.59 0.77 0.36 0.46
American Indian or Alaska Native 4.43 * 3.36 * 1.78 1.41
Native Hawaiian or Other Pacific Islander * * * 2.62 * 1.99
Asian 1.55 1.54 0.93 1.25 0.57 0.98
Two or More Races 2.74 2.87 2.12 2.75 1.63 1.20
Hispanic or Latino 0.98 0.97 0.65 0.74 0.38 0.44
EDUCATION            
< High School 0.94 1.10 0.73 0.91 0.52 0.51
High School Graduate 0.69 0.68 0.52 0.53 0.33 0.36
Some College 0.70 0.72 0.53 0.58 0.35 0.39
College Graduate 1.13 1.01 0.69 0.74 0.45 0.41
CURRENT EMPLOYMENT            
Full-Time 0.72 0.64 0.50 0.50 0.30 0.34
Part-Time 0.74 0.84 0.57 0.66 0.41 0.39
Unemployed 1.15 1.19 0.89 0.98 0.64 0.75
Other1 0.78 0.87 0.61 0.71 0.40 0.39
130401
Table 1.51P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.2126   0.0320   0.2813  
GENDER            
Male 0.7419   0.6552   0.6069  
Female 0.1265   0.0056   0.0264  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.3530   0.0304   0.6362  
White 0.5667   0.2105   0.9079  
Black or African American 0.6163   0.1372   0.2578  
American Indian or Alaska Native *   *   0.9721  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.7905   0.1407   0.2771  
Two or More Races 0.0095   0.4242   0.5160  
Hispanic or Latino 0.3859   0.7007   0.1231  
EDUCATION            
< High School 0.1600   0.1312   0.9849  
High School Graduate 0.6104   0.4030   0.1363  
Some College 0.8209   0.5011   0.7179  
College Graduate 0.1174   0.0362   0.7667  
CURRENT EMPLOYMENT            
Full-Time 0.3082   0.2611   0.0228  
Part-Time 0.5637   0.5439   0.4182  
Unemployed 0.4071   0.0427   0.3431  
Other1 0.7979   0.3357   0.6560  
130401
Table 1.52C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 740 740 338 380 215 247
GENDER            
Male 514 546 234 280 155 172
Female 484 485 225 260 141 162
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 687 688 309 333 192 225
White 743 772 293 310 178 210
Black or African American 223 243 101 147 48 67
American Indian or Alaska Native 48 50 33 24 23 22
Native Hawaiian or Other Pacific Islander * * * 10 * 3
Asian 103 142 48 67 36 37
Two or More Races 103 82 25 21 18 12
Hispanic or Latino 245 301 126 174 91 94
EDUCATION            
< High School 241 313 121 168 88 89
High School Graduate 392 418 167 214 117 133
Some College 452 446 183 210 111 123
College Graduate 496 516 192 175 104 129
CURRENT EMPLOYMENT            
Full-Time 635 647 247 282 161 172
Part-Time 266 301 141 124 78 92
Unemployed 178 195 96 108 67 88
Other1 384 396 153 198 101 104
130401
Table 1.52D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.37 0.37 0.17 0.19 0.11 0.12
GENDER            
Male 0.54 0.57 0.25 0.29 0.16 0.18
Female 0.47 0.46 0.22 0.25 0.14 0.15
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.40 0.40 0.18 0.19 0.11 0.13
White 0.46 0.47 0.21 0.22 0.13 0.15
Black or African American 0.93 0.95 0.44 0.63 0.22 0.30
American Indian or Alaska Native 4.07 4.34 2.99 2.28 2.11 2.09
Native Hawaiian or Other Pacific Islander * * * 1.37 * 0.46
Asian 1.09 1.35 0.51 0.66 0.38 0.38
Two or More Races 3.44 3.02 0.97 0.77 0.72 0.44
Hispanic or Latino 0.91 1.09 0.47 0.63 0.34 0.34
EDUCATION            
< High School 0.82 0.95 0.43 0.56 0.32 0.31
High School Graduate 0.62 0.64 0.28 0.36 0.20 0.23
Some College 0.78 0.74 0.36 0.40 0.22 0.24
College Graduate 0.69 0.68 0.30 0.28 0.16 0.20
CURRENT EMPLOYMENT            
Full-Time 0.50 0.52 0.23 0.26 0.15 0.16
Part-Time 1.01 1.09 0.59 0.51 0.33 0.39
Unemployed 1.69 1.74 1.02 1.08 0.71 0.88
Other1 0.58 0.57 0.24 0.31 0.16 0.16
130401
Table 1.52P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0206   0.0009   0.0991  
GENDER            
Male 0.0608   0.0110   0.1507  
Female 0.1344   0.0244   0.3287  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.2934   0.0106   0.0905  
White 0.4922   0.0883   0.1720  
Black or African American 0.4631   0.0154   0.0454  
American Indian or Alaska Native 0.3723   0.4846   0.6405  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.0582   0.2639   0.6827  
Two or More Races 0.3923   0.8177   0.4853  
Hispanic or Latino 0.0003   0.0152   0.7723  
EDUCATION            
< High School 0.0807   0.2999   0.2778  
High School Graduate 0.1452   0.0732   0.4050  
Some College 0.7507   0.0146   0.5108  
College Graduate 0.1485   0.2307   0.0120  
CURRENT EMPLOYMENT            
Full-Time 0.0026   0.0011   0.1246  
Part-Time 0.8399   1.0000   0.3179  
Unemployed 0.5240   0.6975   0.2417  
Other1 0.8254   0.1221   0.6568  
130401
Table 1.53C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 752 759 357 398 228 263
GENDER            
Male 518 553 246 290 164 180
Female 496 507 238 273 150 171
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 702 707 330 352 204 240
White 771 811 314 339 187 226
Black or African American 230 252 107 151 51 70
American Indian or Alaska Native 50 59 35 38 24 22
Native Hawaiian or Other Pacific Islander * * 16 11 15 5
Asian 109 142 52 71 37 41
Two or More Races 105 87 31 31 23 15
Hispanic or Latino 254 309 132 182 95 98
EDUCATION            
< High School 252 322 130 173 94 93
High School Graduate 407 429 182 228 124 142
Some College 478 471 202 226 124 130
College Graduate 506 529 196 184 106 132
CURRENT EMPLOYMENT            
Full-Time 646 659 254 290 165 180
Part-Time 278 318 151 147 87 101
Unemployed 188 202 106 115 73 92
Other1 393 404 164 209 108 110
130401
Table 1.53D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.32 0.32 0.15 0.17 0.10 0.11
GENDER            
Male 0.46 0.49 0.22 0.26 0.15 0.16
Female 0.41 0.42 0.20 0.22 0.12 0.14
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.35 0.35 0.17 0.18 0.10 0.12
White 0.41 0.42 0.19 0.21 0.12 0.14
Black or African American 0.77 0.79 0.38 0.52 0.19 0.25
American Indian or Alaska Native 3.52 4.00 2.56 2.80 1.76 1.69
Native Hawaiian or Other Pacific Islander * * 1.86 1.24 1.76 0.54
Asian 0.95 1.15 0.46 0.59 0.33 0.36
Two or More Races 2.76 2.55 0.94 0.93 0.71 0.45
Hispanic or Latino 0.75 0.89 0.39 0.52 0.28 0.28
EDUCATION            
< High School 0.71 0.82 0.38 0.49 0.28 0.27
High School Graduate 0.53 0.55 0.26 0.31 0.18 0.20
Some College 0.65 0.62 0.31 0.34 0.20 0.20
College Graduate 0.65 0.64 0.28 0.27 0.15 0.19
CURRENT EMPLOYMENT            
Full-Time 0.45 0.46 0.21 0.24 0.14 0.15
Part-Time 0.74 0.82 0.45 0.43 0.27 0.30
Unemployed 1.19 1.25 0.75 0.80 0.52 0.65
Other1 0.53 0.52 0.23 0.29 0.15 0.15
130401
Table 1.53P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0117   0.0002   0.0592  
GENDER            
Male 0.0552   0.0110   0.2238  
Female 0.0767   0.0031   0.1156  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.2276   0.0022   0.0803  
White 0.4516   0.0566   0.1890  
Black or African American 0.3932   0.0055   0.0215  
American Indian or Alaska Native 0.4245   0.9188   0.6249  
Native Hawaiian or Other Pacific Islander *   0.5691   0.1383  
Asian 0.0585   0.1419   0.4592  
Two or More Races 0.8267   0.7082   0.3894  
Hispanic or Latino 0.0003   0.0166   0.4578  
EDUCATION            
< High School 0.0686   0.2339   0.2226  
High School Graduate 0.1191   0.0515   0.2138  
Some College 0.7839   0.0100   0.4371  
College Graduate 0.1012   0.1072   0.0112  
CURRENT EMPLOYMENT            
Full-Time 0.0012   0.0003   0.0297  
Part-Time 0.7249   0.8257   0.5586  
Unemployed 0.4080   0.3520   0.1803  
Other1 0.7491   0.1128   0.5360  
130401
Table 1.54C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 598 622 302 355 189 211
AGE            
12-17 59 58 48 47 31 32
18-25 130 138 94 97 58 65
26 or Older 589 589 280 332 178 199
GENDER            
Male 436 463 218 276 145 152
Female 360 394 201 232 120 135
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 567 570 275 313 171 195
White 518 522 247 277 152 174
Black or African American 188 189 99 140 49 66
American Indian or Alaska Native 31 41 24 26 22 21
Native Hawaiian or Other Pacific Islander 24 * 11 11 8 2
Asian 83 107 51 67 34 38
Two or More Races 83 75 30 26 23 16
Hispanic or Latino 208 254 125 159 82 74
130401
Table 1.54D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.23 0.24 0.12 0.14 0.07 0.08
AGE            
12-17 0.23 0.23 0.19 0.19 0.12 0.13
18-25 0.38 0.40 0.27 0.28 0.17 0.19
26 or Older 0.30 0.29 0.14 0.17 0.09 0.10
GENDER            
Male 0.35 0.37 0.18 0.22 0.12 0.12
Female 0.27 0.29 0.15 0.17 0.09 0.10
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.26 0.26 0.13 0.14 0.08 0.09
White 0.31 0.31 0.15 0.16 0.09 0.10
Black or African American 0.62 0.62 0.33 0.45 0.16 0.21
American Indian or Alaska Native 2.26 2.70 1.72 1.75 1.48 1.45
Native Hawaiian or Other Pacific Islander 2.69 * 1.15 1.08 0.89 0.16
Asian 0.65 0.78 0.41 0.51 0.27 0.30
Two or More Races 1.91 1.74 0.75 0.65 0.58 0.39
Hispanic or Latino 0.53 0.63 0.32 0.39 0.21 0.18
130401
Table 1.54P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0038   0.0069   0.2255  
AGE            
12-17 0.3445   0.0251   0.9311  
18-25 0.6128   0.3480   0.3641  
26 or Older 0.0033   0.0030   0.3133  
GENDER            
Male 0.0441   0.0327   0.6770  
Female 0.0226   0.0983   0.1512  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.0494   0.0212   0.2324  
White 0.1621   0.3249   0.5229  
Black or African American 0.3496   0.0038   0.0360  
American Indian or Alaska Native 0.3626   0.9186   0.7085  
Native Hawaiian or Other Pacific Islander *   0.8447   0.4070  
Asian 0.1955   0.3652   0.5059  
Two or More Races 0.4700   0.9814   0.4250  
Hispanic or Latino 0.0065   0.1375   0.7459  
130401
Table 1.55C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 59 58 48 47 31 32
GENDER            
Male 41 42 34 35 21 23
Female 42 43 36 33 22 23
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 52 49 42 40 27 27
White 46 45 39 36 21 23
Black or African American 26 24 20 19 13 12
American Indian or Alaska Native 5 5 5 2 3 2
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 12 9 9 5 6 4
Two or More Races 14 13 11 11 7 8
Hispanic or Latino 32 32 26 25 15 17
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 31 30 26 24 15 17
Female, White, Not Hispanic 32 34 28 27 16 17
Male, Black, Not Hispanic 17 17 14 13 8 6
Female, Black, Not Hispanic 19 18 12 15 9 11
Male, Hispanic 22 25 16 20 10 14
Female, Hispanic 25 25 21 18 11 12
130401
Table 1.55D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.23 0.23 0.19 0.19 0.12 0.13
GENDER            
Male 0.32 0.33 0.26 0.27 0.17 0.18
Female 0.35 0.35 0.29 0.27 0.18 0.19
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.26 0.25 0.21 0.21 0.14 0.14
White 0.31 0.30 0.26 0.25 0.15 0.16
Black or African American 0.69 0.64 0.53 0.52 0.36 0.34
American Indian or Alaska Native 3.01 3.01 2.97 1.56 2.07 1.30
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 0.95 0.70 0.73 0.45 0.48 0.34
Two or More Races 1.76 1.63 1.45 1.46 0.91 1.01
Hispanic or Latino 0.59 0.58 0.47 0.46 0.28 0.31
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 0.41 0.41 0.35 0.33 0.20 0.23
Female, White, Not Hispanic 0.44 0.46 0.40 0.38 0.23 0.25
Male, Black, Not Hispanic 0.90 0.91 0.78 0.69 0.46 0.34
Female, Black, Not Hispanic 1.01 0.94 0.67 0.84 0.52 0.60
Male, Hispanic 0.74 0.83 0.56 0.69 0.36 0.48
Female, Hispanic 0.87 0.89 0.74 0.65 0.42 0.43
130401
Table 1.55P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.3445   0.0251   0.9311  
GENDER            
Male 0.9512   0.4227   0.8269  
Female 0.1681   0.0222   0.7357  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.4471   0.0433   1.0000  
White 0.3357   0.0286   0.9312  
Black or African American 0.5463   0.4734   0.7712  
American Indian or Alaska Native 0.6739   0.0510   0.5144  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.3656   0.3523   0.6614  
Two or More Races 0.8102   0.5044   0.7647  
Hispanic or Latino 0.5932   0.3564   0.8722  
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 0.4005   0.1129   0.6841  
Female, White, Not Hispanic 0.6130   0.1374   0.7657  
Male, Black, Not Hispanic 0.4588   0.6813   0.7651  
Female, Black, Not Hispanic 0.9008   0.5665   0.5572  
Male, Hispanic 0.5957   0.6421   0.7590  
Female, Hispanic 0.2074   0.0858   0.5838  
130401
Table 1.56C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 130 138 94 97 58 65
GENDER            
Male 95 96 67 71 42 45
Female 88 91 64 65 37 42
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 115 125 83 89 53 59
White 131 143 83 89 49 51
Black or African American 48 53 28 38 16 22
American Indian or Alaska Native 13 11 8 10 4 3
Native Hawaiian or Other Pacific Islander * * * 3 * 1
Asian 27 28 16 22 8 17
Two or More Races 19 30 14 15 10 9
Hispanic or Latino 63 63 42 42 23 27
EDUCATION            
< High School 59 60 41 40 27 26
High School Graduate 89 96 62 65 35 38
Some College 104 107 59 68 35 40
College Graduate 57 55 33 32 20 17
CURRENT EMPLOYMENT            
Full-Time 99 98 63 64 37 42
Part-Time 78 93 49 57 31 31
Unemployed 53 53 39 41 26 30
Other1 68 69 46 46 27 25
130401
Table 1.56D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.38 0.40 0.27 0.28 0.17 0.19
GENDER            
Male 0.55 0.55 0.39 0.41 0.25 0.26
Female 0.51 0.53 0.38 0.38 0.21 0.25
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.42 0.46 0.30 0.32 0.20 0.21
White 0.52 0.54 0.37 0.40 0.23 0.25
Black or African American 0.87 0.96 0.56 0.72 0.33 0.44
American Indian or Alaska Native 4.14 4.22 3.18 3.42 1.77 1.27
Native Hawaiian or Other Pacific Islander * * * 1.76 * 0.58
Asian 1.38 1.45 0.82 1.18 0.41 0.92
Two or More Races 2.50 2.88 1.82 1.90 1.31 1.12
Hispanic or Latino 0.90 0.88 0.59 0.59 0.32 0.38
EDUCATION            
< High School 0.86 1.00 0.66 0.72 0.45 0.48
High School Graduate 0.64 0.66 0.48 0.48 0.29 0.31
Some College 0.62 0.67 0.42 0.49 0.27 0.32
College Graduate 0.98 0.91 0.62 0.57 0.39 0.32
CURRENT EMPLOYMENT            
Full-Time 0.65 0.59 0.45 0.44 0.28 0.31
Part-Time 0.67 0.81 0.47 0.55 0.32 0.32
Unemployed 1.06 1.13 0.81 0.92 0.56 0.71
Other1 0.70 0.72 0.53 0.53 0.33 0.32
130401
Table 1.56P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6128   0.3480   0.3641  
GENDER            
Male 0.8299   0.9317   0.6789  
Female 0.5992   0.1345   0.0596  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.7942   0.1842   0.6760  
White 0.7894   0.5542   0.9026  
Black or African American 0.5209   0.1765   0.2925  
American Indian or Alaska Native 0.0702   0.9524   0.9406  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.8573   0.1418   0.1559  
Two or More Races 0.0015   0.5802   0.8111  
Hispanic or Latino 0.5565   0.5436   0.1940  
EDUCATION            
< High School 0.2037   0.6310   0.9534  
High School Graduate 0.7586   0.6267   0.1526  
Some College 0.7678   0.2749   0.5206  
College Graduate 0.7473   0.8711   0.4754  
CURRENT EMPLOYMENT            
Full-Time 0.3974   0.5270   0.1119  
Part-Time 0.8571   0.8118   0.2951  
Unemployed 0.5169   0.1694   0.3457  
Other1 0.5065   0.8780   0.8337  
130401
Table 1.57C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 589 589 280 332 178 199
GENDER            
Male 433 448 207 263 138 144
Female 344 375 184 216 110 126
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 550 544 253 291 159 184
White 557 566 233 261 144 167
Black or African American 197 206 93 143 45 62
American Indian or Alaska Native 27 38 21 24 20 21
Native Hawaiian or Other Pacific Islander * * * 10 * 1
Asian 75 105 48 63 33 34
Two or More Races 78 67 22 19 18 11
Hispanic or Latino 198 241 115 150 78 70
EDUCATION            
< High School 188 244 106 158 80 74
High School Graduate 322 341 147 185 104 97
Some College 347 353 157 182 88 99
College Graduate 335 342 148 140 76 112
CURRENT EMPLOYMENT            
Full-Time 486 481 217 247 136 149
Part-Time 196 226 117 103 56 68
Unemployed 142 173 72 92 56 69
Other1 298 294 117 177 81 76
130401
Table 1.57D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.30 0.29 0.14 0.17 0.09 0.10
GENDER            
Male 0.46 0.47 0.22 0.27 0.15 0.15
Female 0.33 0.36 0.18 0.21 0.11 0.12
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.32 0.31 0.15 0.17 0.09 0.11
White 0.37 0.36 0.17 0.19 0.11 0.12
Black or African American 0.83 0.83 0.41 0.61 0.20 0.27
American Indian or Alaska Native 2.64 3.50 2.08 2.25 1.91 2.00
Native Hawaiian or Other Pacific Islander * * * 1.27 * 0.14
Asian 0.79 1.00 0.51 0.62 0.35 0.35
Two or More Races 2.80 2.43 0.86 0.70 0.71 0.42
Hispanic or Latino 0.74 0.87 0.43 0.54 0.29 0.25
EDUCATION            
< High School 0.66 0.77 0.38 0.53 0.29 0.26
High School Graduate 0.53 0.55 0.25 0.31 0.18 0.17
Some College 0.62 0.63 0.31 0.35 0.18 0.19
College Graduate 0.50 0.49 0.23 0.22 0.12 0.18
CURRENT EMPLOYMENT            
Full-Time 0.41 0.41 0.21 0.23 0.13 0.14
Part-Time 0.80 0.88 0.50 0.43 0.24 0.29
Unemployed 1.42 1.62 0.76 0.95 0.60 0.71
Other1 0.46 0.44 0.19 0.27 0.13 0.12
130401
Table 1.57P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0033   0.0030   0.3133  
GENDER            
Male 0.0453   0.0151   0.5901  
Female 0.0168   0.0864   0.3277  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.0446   0.0178   0.2544  
White 0.1147   0.2144   0.4705  
Black or African American 0.4884   0.0108   0.0668  
American Indian or Alaska Native 0.1487   0.9079   0.7925  
Native Hawaiian or Other Pacific Islander *   *   *  
Asian 0.1132   0.5108   0.7828  
Two or More Races 0.9328   0.9775   0.4222  
Hispanic or Latino 0.0045   0.0460   0.9540  
EDUCATION            
< High School 0.1247   0.1416   0.3083  
High School Graduate 0.0484   0.2432   0.8704  
Some College 0.0901   0.0128   0.4098  
College Graduate 0.3764   0.5762   0.0349  
CURRENT EMPLOYMENT            
Full-Time 0.0014   0.0284   0.4546  
Part-Time 0.5504   0.8038   0.2303  
Unemployed 0.2717   0.1880   0.2807  
Other1 0.8380   0.0838   0.4643  
130401
Table 1.58C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 597 614 297 349 187 210
GENDER            
Male 436 459 216 273 144 151
Female 358 392 196 228 118 134
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 564 565 270 308 169 195
White 583 600 252 286 152 178
Black or African American 204 212 99 147 48 66
American Indian or Alaska Native 30 40 23 26 21 21
Native Hawaiian or Other Pacific Islander 23 * 10 10 8 2
Asian 81 106 51 66 33 38
Two or More Races 81 74 27 24 22 14
Hispanic or Latino 205 250 121 156 81 73
EDUCATION            
< High School 200 250 114 161 84 77
High School Graduate 341 350 162 196 111 105
Some College 369 375 172 196 99 106
College Graduate 342 353 152 145 78 113
CURRENT EMPLOYMENT            
Full-Time 498 490 224 254 139 156
Part-Time 208 247 126 119 64 75
Unemployed 151 181 80 99 62 73
Other1 305 299 126 184 86 80
130401
Table 1.58D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.26 0.26 0.13 0.15 0.08 0.09
GENDER            
Male 0.39 0.41 0.19 0.24 0.13 0.13
Female 0.30 0.32 0.16 0.19 0.10 0.11
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.28 0.28 0.14 0.15 0.09 0.10
White 0.33 0.33 0.16 0.18 0.10 0.11
Black or African American 0.70 0.69 0.36 0.51 0.18 0.24
American Indian or Alaska Native 2.47 2.99 1.85 1.95 1.60 1.61
Native Hawaiian or Other Pacific Islander 2.79 * 1.17 1.09 0.96 0.16
Asian 0.71 0.86 0.45 0.56 0.30 0.33
Two or More Races 2.27 2.11 0.83 0.72 0.66 0.42
Hispanic or Latino 0.60 0.72 0.36 0.45 0.24 0.21
EDUCATION            
< High School 0.57 0.67 0.33 0.46 0.25 0.23
High School Graduate 0.46 0.47 0.23 0.27 0.16 0.15
Some College 0.52 0.53 0.27 0.30 0.16 0.17
College Graduate 0.47 0.46 0.22 0.21 0.11 0.16
CURRENT EMPLOYMENT            
Full-Time 0.37 0.37 0.19 0.21 0.12 0.13
Part-Time 0.59 0.68 0.38 0.36 0.20 0.23
Unemployed 1.01 1.18 0.57 0.70 0.44 0.52
Other1 0.42 0.40 0.18 0.25 0.12 0.11
130401
Table 1.58P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Demographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0029   0.0020   0.2154  
GENDER            
Male 0.0453   0.0227   0.6974  
Female 0.0145   0.0362   0.1269  
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 0.0434   0.0084   0.2295  
White 0.1460   0.1953   0.5300  
Black or African American 0.3877   0.0043   0.0362  
American Indian or Alaska Native 0.3272   0.8609   0.7690  
Native Hawaiian or Other Pacific Islander *   0.9279   0.3674  
Asian 0.1625   0.3050   0.4629  
Two or More Races 0.4430   0.7436   0.4523  
Hispanic or Latino 0.0044   0.0898   0.7120  
EDUCATION            
< High School 0.1250   0.1848   0.2600  
High School Graduate 0.0456   0.2086   0.7382  
Some College 0.1101   0.0065   0.3135  
College Graduate 0.3417   0.5822   0.0499  
CURRENT EMPLOYMENT            
Full-Time 0.0005   0.0150   0.2201  
Part-Time 0.6303   0.7636   0.5299  
Unemployed 0.2463   0.1202   0.2031  
Other1 1.0000   0.1298   0.4940  
130328
Table 1.59C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 1,036 956 603 648 460 492
GEOGRAPHIC DIVISION            
Northeast 445 398 248 261 194 209
New England 203 181 119 111 97 101
Middle Atlantic 394 353 219 236 169 183
Midwest 389 368 212 248 176 166
East North Central 335 296 183 211 154 141
West North Central 217 236 108 134 82 85
South 595 602 370 374 253 285
South Atlantic 471 461 290 289 195 225
East South Central 215 219 120 132 101 86
West South Central 313 332 198 192 137 148
West 582 513 342 354 273 295
Mountain 254 233 151 152 105 118
Pacific 522 457 310 319 252 268
COUNTY TYPE            
Large Metro 1,262 1,221 524 568 381 415
Small Metro 874 916 390 416 275 294
250K - 1 Mil. Pop. 732 759 300 331 218 240
< 250K Pop. 551 575 247 256 165 177
Nonmetro 583 611 225 239 164 146
Urbanized 410 440 171 182 121 117
Less Urbanized 408 384 140 154 104 85
Completely Rural 177 244 59 55 43 41
130328
Table 1.59D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.40 0.37 0.23 0.25 0.18 0.19
GEOGRAPHIC DIVISION            
Northeast 0.95 0.84 0.53 0.55 0.41 0.44
New England 1.65 1.46 0.97 0.89 0.79 0.82
Middle Atlantic 1.14 1.02 0.63 0.68 0.49 0.53
Midwest 0.70 0.66 0.38 0.44 0.32 0.30
East North Central 0.87 0.76 0.47 0.54 0.40 0.36
West North Central 1.27 1.38 0.64 0.78 0.48 0.50
South 0.63 0.62 0.39 0.39 0.27 0.30
South Atlantic 0.94 0.91 0.58 0.57 0.39 0.44
East South Central 1.40 1.42 0.78 0.86 0.66 0.56
West South Central 1.05 1.10 0.67 0.64 0.46 0.49
West 0.97 0.85 0.57 0.58 0.46 0.49
Mountain 1.40 1.27 0.83 0.83 0.58 0.64
Pacific 1.25 1.08 0.74 0.76 0.60 0.64
COUNTY TYPE            
Large Metro 0.59 0.53 0.34 0.36 0.26 0.28
Small Metro 0.63 0.65 0.42 0.47 0.32 0.35
250K - 1 Mil. Pop. 0.79 0.77 0.49 0.56 0.39 0.42
< 250K Pop. 1.12 1.16 0.75 0.82 0.54 0.61
Nonmetro 0.91 0.91 0.46 0.49 0.35 0.33
Urbanized 1.30 1.37 0.77 0.86 0.58 0.60
Less Urbanized 1.27 1.23 0.62 0.66 0.48 0.40
Completely Rural 2.26 2.82 1.22 1.01 0.95 0.76
130328
Table 1.59P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0649   0.0009   0.0723  
GEOGRAPHIC DIVISION            
Northeast 0.5394   0.1553   0.5026  
New England 0.3990   0.4737   0.2952  
Middle Atlantic 0.8054   0.2203   0.8510  
Midwest 0.2070   0.0302   0.8766  
East North Central 0.0386   0.0203   0.6884  
West North Central 0.4233   0.6807   0.6990  
South 0.7617   0.1737   0.4889  
South Atlantic 0.3998   0.4056   0.1095  
East South Central 0.2054   0.9852   0.0920  
West South Central 0.8259   0.1785   0.9599  
West 0.0765   0.0447   0.0604  
Mountain 0.2212   0.1098   0.1334  
Pacific 0.1620   0.1383   0.1594  
COUNTY TYPE            
Large Metro 0.4862   0.0023   0.0747  
Small Metro 0.0088   0.1086   0.2208  
250K - 1 Mil. Pop. 0.0659   0.1406   0.2999  
< 250K Pop. 0.0491   0.4675   0.5145  
Nonmetro 0.7826   0.6363   0.5195  
Urbanized 0.8265   0.8844   0.7928  
Less Urbanized 0.7622   0.3431   0.5880  
Completely Rural 0.5774   0.2783   0.5016  
130328
Table 1.60C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 103 92 93 83 68 63
GEOGRAPHIC DIVISION            
Northeast 38 36 36 33 25 26
New England 18 18 16 16 13 13
Middle Atlantic 33 31 32 29 22 22
Midwest 40 39 32 32 24 23
East North Central 32 32 25 27 19 19
West North Central 23 23 19 17 14 13
South 63 60 57 53 42 42
South Atlantic 46 45 42 39 32 31
East South Central 22 20 19 18 13 12
West South Central 35 37 32 32 25 26
West 61 53 56 47 39 36
Mountain 27 27 24 24 17 18
Pacific 54 45 51 41 36 31
COUNTY TYPE            
Large Metro 103 100 85 83 57 59
Small Metro 69 61 61 50 42 35
250K - 1 Mil. Pop. 58 48 52 40 35 29
< 250K Pop. 40 41 33 32 25 20
Nonmetro 45 40 38 33 24 25
Urbanized 31 29 27 23 19 15
Less Urbanized 34 27 25 21 15 16
Completely Rural 15 15 11 14 9 12
130328
Table 1.60D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.41 0.37 0.37 0.33 0.27 0.25
GEOGRAPHIC DIVISION            
Northeast 0.88 0.85 0.84 0.77 0.59 0.60
New England 1.58 1.61 1.44 1.44 1.13 1.18
Middle Atlantic 1.05 1.00 1.02 0.91 0.68 0.71
Midwest 0.73 0.72 0.59 0.58 0.44 0.42
East North Central 0.85 0.84 0.66 0.72 0.50 0.50
West North Central 1.43 1.40 1.18 1.04 0.85 0.81
South 0.68 0.65 0.62 0.57 0.45 0.45
South Atlantic 1.00 0.96 0.91 0.85 0.68 0.66
East South Central 1.47 1.36 1.25 1.22 0.85 0.81
West South Central 1.12 1.15 1.02 1.00 0.78 0.80
West 1.01 0.89 0.93 0.79 0.65 0.60
Mountain 1.44 1.45 1.29 1.29 0.91 0.98
Pacific 1.31 1.10 1.23 0.98 0.86 0.76
COUNTY TYPE            
Large Metro 0.61 0.57 0.54 0.50 0.38 0.38
Small Metro 0.66 0.62 0.65 0.56 0.50 0.42
250K - 1 Mil. Pop. 0.84 0.72 0.79 0.65 0.60 0.50
< 250K Pop. 1.11 1.23 1.12 1.11 0.90 0.80
Nonmetro 0.96 0.84 0.85 0.74 0.59 0.60
Urbanized 1.47 1.13 1.35 1.06 1.01 0.83
Less Urbanized 1.43 1.33 1.16 1.11 0.75 0.90
Completely Rural 3.21 2.68 2.60 2.59 2.16 2.49
130328
Table 1.60P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0209   0.0423   0.1309  
GEOGRAPHIC DIVISION            
Northeast 0.0182   0.0333   0.2955  
New England 0.1776   0.2720   0.6231  
Middle Atlantic 0.0496   0.0677   0.3562  
Midwest 0.8110   0.9266   0.9280  
East North Central 0.6240   0.4999   0.9585  
West North Central 0.3008   0.2890   0.9335  
South 0.6675   0.4189   0.8012  
South Atlantic 0.1539   0.1359   0.1195  
East South Central 0.8350   0.5966   0.0477  
West South Central 0.3423   0.8073   0.5838  
West 0.0046   0.0041   0.0254  
Mountain 0.5590   0.3916   0.9546  
Pacific 0.0034   0.0057   0.0121  
COUNTY TYPE            
Large Metro 0.1469   0.3511   0.5295  
Small Metro 0.1754   0.1220   0.0311  
250K - 1 Mil. Pop. 0.0807   0.0484   0.1508  
< 250K Pop. 0.8060   0.8510   0.0930  
Nonmetro 0.1859   0.1152   0.7035  
Urbanized 0.3725   0.0502   0.4791  
Less Urbanized 0.4389   0.6713   0.4839  
Completely Rural 0.4487   0.9092   0.1556  
130328
Table 1.61C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 174 175 172 174 142 138
GEOGRAPHIC DIVISION            
Northeast 69 66 71 69 56 60
New England 34 36 36 39 29 33
Middle Atlantic 61 56 61 58 48 50
Midwest 69 63 65 66 56 56
East North Central 60 51 58 55 51 50
West North Central 36 39 33 36 27 24
South 111 107 111 105 91 74
South Atlantic 81 83 80 85 70 60
East South Central 37 32 31 31 26 24
West South Central 60 58 62 50 49 36
West 91 106 84 102 79 87
Mountain 41 40 40 41 36 36
Pacific 81 98 75 93 70 79
COUNTY TYPE            
Large Metro 270 269 197 211 142 149
Small Metro 231 225 166 180 121 107
250K - 1 Mil. Pop. 146 167 101 133 75 81
< 250K Pop. 179 153 130 120 94 68
Nonmetro 115 99 86 64 63 43
Urbanized 94 72 72 49 52 31
Less Urbanized 70 69 46 42 34 29
Completely Rural 29 24 23 16 15 10
130328
Table 1.61D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.51 0.51 0.50 0.50 0.42 0.40
GEOGRAPHIC DIVISION            
Northeast 1.13 1.08 1.16 1.12 0.91 0.97
New England 2.14 2.23 2.25 2.38 1.81 2.04
Middle Atlantic 1.34 1.24 1.36 1.28 1.06 1.10
Midwest 0.94 0.86 0.89 0.89 0.77 0.76
East North Central 1.19 1.01 1.15 1.08 1.00 0.99
West North Central 1.57 1.69 1.47 1.58 1.19 1.05
South 0.88 0.84 0.88 0.82 0.72 0.58
South Atlantic 1.26 1.26 1.25 1.30 1.08 0.92
East South Central 1.83 1.58 1.54 1.52 1.27 1.16
West South Central 1.43 1.39 1.49 1.20 1.17 0.85
West 1.10 1.28 1.03 1.22 0.96 1.04
Mountain 1.64 1.62 1.61 1.65 1.46 1.45
Pacific 1.40 1.69 1.31 1.60 1.22 1.35
COUNTY TYPE            
Large Metro 0.71 0.72 0.70 0.69 0.59 0.60
Small Metro 0.95 0.92 0.88 1.00 0.75 0.69
250K - 1 Mil. Pop. 1.09 1.12 1.06 1.24 0.86 0.89
< 250K Pop. 1.60 1.67 1.55 1.71 1.35 1.02
Nonmetro 1.17 1.11 1.22 0.96 1.00 0.75
Urbanized 1.61 1.68 1.81 1.44 1.55 1.14
Less Urbanized 1.65 1.71 1.56 1.45 1.26 1.09
Completely Rural 3.85 3.44 3.79 2.76 2.60 1.85
130328
Table 1.61P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.2442   0.0958   0.8661  
GEOGRAPHIC DIVISION            
Northeast 0.1221   0.0520   0.1771  
New England 0.4587   0.5608   0.8345  
Middle Atlantic 0.1773   0.0566   0.1395  
Midwest 0.4393   0.6439   0.6130  
East North Central 0.6228   0.8173   0.6161  
West North Central 0.5229   0.6219   0.0457  
South 0.7888   0.5413   0.4420  
South Atlantic 0.2991   0.9173   0.6334  
East South Central 0.7909   0.9188   0.4145  
West South Central 0.2302   0.1687   0.7713  
West 0.3903   0.5860   0.8869  
Mountain 1.0000   0.6086   0.7424  
Pacific 0.3447   0.7319   0.7437  
COUNTY TYPE            
Large Metro 0.0135   0.0282   0.4338  
Small Metro 0.7511   0.4934   0.4748  
250K - 1 Mil. Pop. 0.4247   0.9135   0.4568  
< 250K Pop. 0.6695   0.1634   0.8203  
Nonmetro 0.1240   0.1620   0.1443  
Urbanized 0.0707   0.1293   0.0784  
Less Urbanized 0.8602   0.6861   0.9248  
Completely Rural 0.5155   0.7837   0.4875  
130328
Table 1.62C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 1,011 925 550 583 420 452
GEOGRAPHIC DIVISION            
Northeast 438 381 223 230 177 187
New England 200 175 107 103 88 89
Middle Atlantic 390 336 197 205 154 165
Midwest 377 352 192 224 156 152
East North Central 325 286 169 195 139 131
West North Central 210 224 96 109 73 74
South 586 588 330 333 219 261
South Atlantic 461 455 245 255 156 203
East South Central 215 209 112 122 99 79
West South Central 302 319 191 171 130 136
West 557 499 311 329 246 274
Mountain 241 226 135 140 91 103
Pacific 501 447 282 295 228 251
COUNTY TYPE            
Large Metro 1,174 1,135 459 492 343 367
Small Metro 782 825 315 343 224 262
250K - 1 Mil. Pop. 677 697 257 288 187 224
< 250K Pop. 469 492 178 189 113 144
Nonmetro 522 554 184 214 137 130
Urbanized 360 396 139 162 98 106
Less Urbanized 360 344 110 136 86 72
Completely Rural 147 223 44 42 34 32
130328
Table 1.62D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.51 0.46 0.28 0.29 0.21 0.23
GEOGRAPHIC DIVISION            
Northeast 1.20 1.04 0.61 0.62 0.48 0.51
New England 2.08 1.81 1.12 1.07 0.92 0.92
Middle Atlantic 1.45 1.24 0.73 0.76 0.57 0.61
Midwest 0.88 0.82 0.45 0.52 0.36 0.35
East North Central 1.09 0.96 0.57 0.65 0.47 0.44
West North Central 1.60 1.70 0.74 0.83 0.56 0.56
South 0.80 0.79 0.45 0.45 0.30 0.35
South Atlantic 1.18 1.15 0.63 0.64 0.40 0.51
East South Central 1.82 1.76 0.95 1.02 0.83 0.66
West South Central 1.35 1.40 0.86 0.75 0.58 0.60
West 1.22 1.08 0.68 0.71 0.54 0.59
Mountain 1.74 1.61 0.97 0.99 0.66 0.73
Pacific 1.58 1.39 0.89 0.92 0.72 0.78
COUNTY TYPE            
Large Metro 0.76 0.67 0.41 0.42 0.31 0.33
Small Metro 0.78 0.80 0.47 0.53 0.35 0.41
250K - 1 Mil. Pop. 0.97 0.94 0.56 0.64 0.43 0.51
< 250K Pop. 1.42 1.45 0.79 0.88 0.53 0.70
Nonmetro 1.11 1.11 0.51 0.59 0.39 0.38
Urbanized 1.63 1.72 0.89 1.03 0.66 0.71
Less Urbanized 1.53 1.50 0.67 0.80 0.53 0.45
Completely Rural 2.52 3.30 1.30 1.06 0.99 0.79
130328
Table 1.62P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0617   0.0004   0.0215  
GEOGRAPHIC DIVISION            
Northeast 0.5652   0.1695   0.6272  
New England 0.4060   0.4551   0.2314  
Middle Atlantic 0.8354   0.2476   0.9134  
Midwest 0.2438   0.0233   0.7273  
East North Central 0.0497   0.0202   0.7981  
West North Central 0.3881   0.5956   0.7799  
South 0.7677   0.2396   0.3208  
South Atlantic 0.3736   0.4865   0.0884  
East South Central 0.2175   0.9228   0.2163  
West South Central 0.9080   0.2659   0.8046  
West 0.0519   0.0107   0.0132  
Mountain 0.1938   0.0861   0.1224  
Pacific 0.1229   0.0440   0.0418  
COUNTY TYPE            
Large Metro 0.6653   0.0058   0.0784  
Small Metro 0.0043   0.0565   0.0519  
250K - 1 Mil. Pop. 0.0269   0.0411   0.1158  
< 250K Pop. 0.0660   0.6469   0.2356  
Nonmetro 0.5120   0.1766   0.8441  
Urbanized 0.5086   0.2310   0.5673  
Less Urbanized 0.7263   0.2612   0.4132  
Completely Rural 0.6888   0.2972   0.4476  
130328
Table 1.63C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 1,035 953 589 639 453 485
GEOGRAPHIC DIVISION            
Northeast 448 392 243 256 191 206
New England 204 178 115 108 95 99
Middle Atlantic 398 348 216 232 167 181
Midwest 387 362 207 244 172 165
East North Central 334 294 179 206 151 139
West North Central 213 229 106 133 80 84
South 598 603 364 366 251 279
South Atlantic 473 466 287 286 193 221
East South Central 216 216 118 129 101 83
West South Central 312 326 194 185 137 144
West 579 512 332 350 268 291
Mountain 251 231 146 149 102 114
Pacific 521 457 300 316 248 266
COUNTY TYPE            
Large Metro 1,239 1,202 506 552 373 402
Small Metro 854 893 375 405 270 289
250K - 1 Mil. Pop. 718 740 285 324 210 237
< 250K Pop. 533 556 239 244 161 172
Nonmetro 564 599 213 232 159 141
Urbanized 398 430 163 175 117 114
Less Urbanized 392 376 130 149 101 81
Completely Rural 167 236 54 47 40 35
130328
Table 1.63D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.44 0.41 0.25 0.27 0.19 0.21
GEOGRAPHIC DIVISION            
Northeast 1.05 0.91 0.57 0.60 0.45 0.48
New England 1.82 1.57 1.02 0.96 0.85 0.87
Middle Atlantic 1.27 1.10 0.69 0.73 0.53 0.57
Midwest 0.77 0.72 0.41 0.48 0.34 0.33
East North Central 0.96 0.84 0.51 0.59 0.43 0.40
West North Central 1.39 1.48 0.69 0.86 0.52 0.55
South 0.70 0.69 0.42 0.42 0.29 0.32
South Atlantic 1.04 1.01 0.63 0.62 0.42 0.48
East South Central 1.57 1.55 0.86 0.92 0.73 0.60
West South Central 1.17 1.21 0.73 0.69 0.52 0.53
West 1.07 0.94 0.62 0.64 0.50 0.53
Mountain 1.54 1.40 0.90 0.90 0.63 0.69
Pacific 1.39 1.20 0.80 0.83 0.66 0.70
COUNTY TYPE            
Large Metro 0.66 0.59 0.37 0.39 0.29 0.30
Small Metro 0.69 0.70 0.45 0.51 0.34 0.38
250K - 1 Mil. Pop. 0.86 0.83 0.52 0.62 0.41 0.47
< 250K Pop. 1.24 1.26 0.82 0.87 0.59 0.65
Nonmetro 1.00 1.00 0.50 0.53 0.38 0.35
Urbanized 1.45 1.52 0.86 0.93 0.65 0.65
Less Urbanized 1.39 1.35 0.65 0.72 0.52 0.42
Completely Rural 2.38 3.03 1.28 1.01 0.97 0.75
130328
Table 1.63P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0427   0.0002   0.0396  
GEOGRAPHIC DIVISION            
Northeast 0.4302   0.0824   0.4057  
New England 0.3469   0.3693   0.2561  
Middle Atlantic 0.6929   0.1368   0.7469  
Midwest 0.2037   0.0269   0.8830  
East North Central 0.0454   0.0228   0.6889  
West North Central 0.4712   0.5637   0.6803  
South 0.8119   0.2072   0.5021  
South Atlantic 0.5002   0.5433   0.1664  
East South Central 0.2059   0.9487   0.1611  
West South Central 0.7430   0.1539   0.8861  
West 0.0393   0.0116   0.0260  
Mountain 0.1954   0.0713   0.1260  
Pacific 0.0921   0.0509   0.0768  
COUNTY TYPE            
Large Metro 0.3894   0.0012   0.0546  
Small Metro 0.0069   0.0618   0.1224  
250K - 1 Mil. Pop. 0.0442   0.0737   0.2116  
< 250K Pop. 0.0621   0.4624   0.3589  
Nonmetro 0.7138   0.4507   0.4745  
Urbanized 0.7813   0.6468   0.8804  
Less Urbanized 0.7286   0.2886   0.5106  
Completely Rural 0.6245   0.2438   0.3284  
130328
Table 1.64C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 1,013 1,005 514 556 409 431
GEOGRAPHIC DIVISION            
Northeast 436 397 226 245 180 185
New England 190 179 115 105 91 93
Middle Atlantic 393 353 195 222 155 160
Midwest 384 372 189 209 154 140
East North Central 330 299 161 171 134 119
West North Central 205 236 93 123 69 75
South 601 631 301 309 220 234
South Atlantic 463 493 237 245 173 194
East South Central 212 216 98 102 87 68
West South Central 320 321 163 157 115 115
West 549 541 297 320 241 273
Mountain 239 250 123 139 91 106
Pacific 491 479 272 286 222 249
COUNTY TYPE            
Large Metro 1,196 1,139 453 469 347 354
Small Metro 794 861 319 357 231 270
250K - 1 Mil. Pop. 665 708 246 288 184 221
< 250K Pop. 494 540 196 223 135 165
Nonmetro 525 558 193 169 139 126
Urbanized 363 394 148 129 104 102
Less Urbanized 372 355 122 110 90 74
Completely Rural 156 230 45 49 30 34
130328
Table 1.64D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.39 0.39 0.20 0.21 0.16 0.17
GEOGRAPHIC DIVISION            
Northeast 0.93 0.84 0.48 0.52 0.38 0.39
New England 1.54 1.44 0.93 0.84 0.74 0.75
Middle Atlantic 1.14 1.02 0.56 0.64 0.45 0.46
Midwest 0.69 0.67 0.34 0.37 0.28 0.25
East North Central 0.85 0.77 0.42 0.44 0.35 0.31
West North Central 1.21 1.38 0.55 0.72 0.41 0.44
South 0.63 0.65 0.32 0.32 0.23 0.24
South Atlantic 0.92 0.97 0.47 0.48 0.34 0.38
East South Central 1.39 1.40 0.64 0.66 0.57 0.44
West South Central 1.08 1.07 0.55 0.52 0.39 0.38
West 0.92 0.89 0.50 0.53 0.40 0.45
Mountain 1.32 1.36 0.67 0.75 0.50 0.57
Pacific 1.18 1.14 0.65 0.68 0.53 0.59
COUNTY TYPE            
Large Metro 0.57 0.55 0.29 0.31 0.24 0.24
Small Metro 0.62 0.66 0.35 0.42 0.27 0.33
250K - 1 Mil. Pop. 0.79 0.77 0.41 0.50 0.33 0.40
< 250K Pop. 1.05 1.20 0.62 0.76 0.46 0.59
Nonmetro 0.87 0.90 0.42 0.37 0.32 0.29
Urbanized 1.31 1.36 0.70 0.64 0.56 0.52
Less Urbanized 1.24 1.25 0.56 0.51 0.42 0.36
Completely Rural 2.18 2.84 0.95 0.90 0.67 0.63
130328
Table 1.64P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0949   0.0450   0.2989  
GEOGRAPHIC DIVISION            
Northeast 0.3826   0.1524   0.6159  
New England 0.0523   0.3732   0.2693  
Middle Atlantic 0.9826   0.2495   0.9593  
Midwest 0.0838   0.2229   0.9012  
East North Central 0.0313   0.2160   0.9221  
West North Central 0.8376   0.7104   0.9404  
South 0.9903   0.3951   0.7713  
South Atlantic 0.5670   0.3637   0.1343  
East South Central 0.2953   0.5491   0.0239  
West South Central 0.8912   0.5052   0.8111  
West 0.2000   0.4413   0.2378  
Mountain 0.2179   0.1962   0.2732  
Pacific 0.3975   0.7698   0.3943  
COUNTY TYPE            
Large Metro 0.8740   0.2908   0.7863  
Small Metro 0.0038   0.0242   0.1304  
250K - 1 Mil. Pop. 0.0251   0.1434   0.2965  
< 250K Pop. 0.0561   0.0565   0.2551  
Nonmetro 0.5633   0.9922   0.9220  
Urbanized 0.5981   0.8096   0.6948  
Less Urbanized 0.7561   0.6925   0.7414  
Completely Rural 0.8336   0.5740   0.6930  
130328
Table 1.65C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 89 82 83 75 61 55
GEOGRAPHIC DIVISION            
Northeast 34 31 34 28 25 23
New England 16 15 15 13 12 12
Middle Atlantic 30 27 30 26 21 20
Midwest 32 32 27 27 20 20
East North Central 26 25 21 23 16 17
West North Central 19 19 16 14 12 12
South 54 54 49 50 36 35
South Atlantic 41 40 38 37 29 26
East South Central 17 17 15 15 11 10
West South Central 29 31 26 29 19 20
West 53 46 51 42 34 32
Mountain 21 24 20 20 16 15
Pacific 49 40 48 37 31 28
COUNTY TYPE            
Large Metro 78 83 70 72 47 48
Small Metro 58 48 54 43 40 30
250K - 1 Mil. Pop. 50 38 46 34 33 25
< 250K Pop. 31 30 29 27 23 18
Nonmetro 33 31 29 28 19 22
Urbanized 23 19 21 17 15 13
Less Urbanized 22 23 18 19 10 15
Completely Rural 11 13 9 12 7 11
130328
Table 1.65D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.35 0.33 0.33 0.30 0.24 0.22
GEOGRAPHIC DIVISION            
Northeast 0.80 0.73 0.78 0.67 0.57 0.54
New England 1.43 1.37 1.36 1.19 1.09 1.06
Middle Atlantic 0.94 0.87 0.94 0.82 0.66 0.62
Midwest 0.58 0.58 0.49 0.49 0.38 0.37
East North Central 0.68 0.67 0.56 0.60 0.43 0.44
West North Central 1.15 1.17 0.99 0.88 0.73 0.72
South 0.59 0.58 0.53 0.53 0.39 0.38
South Atlantic 0.88 0.86 0.83 0.79 0.62 0.56
East South Central 1.13 1.17 1.00 1.02 0.75 0.66
West South Central 0.92 0.98 0.82 0.89 0.60 0.64
West 0.88 0.78 0.86 0.70 0.57 0.53
Mountain 1.12 1.29 1.08 1.07 0.85 0.80
Pacific 1.17 0.96 1.15 0.89 0.75 0.68
COUNTY TYPE            
Large Metro 0.51 0.51 0.47 0.45 0.33 0.32
Small Metro 0.62 0.54 0.60 0.50 0.48 0.37
250K - 1 Mil. Pop. 0.74 0.62 0.70 0.55 0.57 0.44
< 250K Pop. 1.13 1.08 1.12 1.02 0.88 0.74
Nonmetro 0.77 0.73 0.68 0.64 0.48 0.54
Urbanized 1.20 0.97 1.13 0.87 0.82 0.71
Less Urbanized 1.10 1.24 0.93 1.01 0.56 0.82
Completely Rural 2.47 2.34 2.05 2.33 1.83 2.24
130328
Table 1.65P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.2539   0.1093   0.0458  
GEOGRAPHIC DIVISION            
Northeast 0.1952   0.2598   0.4510  
New England 0.2237   0.1397   0.2918  
Middle Atlantic 0.3936   0.5872   0.7753  
Midwest 0.3220   0.2738   0.4404  
East North Central 0.2606   0.1876   0.7098  
West North Central 0.8632   0.9548   0.4308  
South 0.4063   0.4425   0.8767  
South Atlantic 0.1027   0.1868   0.2397  
East South Central 0.5200   0.2416   0.0112  
West South Central 0.7269   0.8523   0.5741  
West 0.0096   0.0008   0.0011  
Mountain 0.4766   0.0492   0.1661  
Pacific 0.0104   0.0054   0.0035  
COUNTY TYPE            
Large Metro 0.9422   0.6625   0.1903  
Small Metro 0.0306   0.0360   0.0145  
250K - 1 Mil. Pop. 0.0343   0.0118   0.0589  
< 250K Pop. 0.5218   0.9297   0.1454  
Nonmetro 0.7029   0.4936   0.2819  
Urbanized 0.0904   0.0241   0.5803  
Less Urbanized 0.2780   0.3628   0.0836  
Completely Rural 0.8889   0.4389   0.3267  
130328
Table 1.66C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 177 178 167 171 135 133
GEOGRAPHIC DIVISION            
Northeast 69 64 71 69 55 57
New England 33 34 35 36 28 30
Middle Atlantic 61 55 62 59 47 48
Midwest 70 66 63 60 52 49
East North Central 62 49 56 50 47 44
West North Central 36 44 31 34 25 23
South 114 107 106 101 83 72
South Atlantic 86 82 77 80 63 58
East South Central 36 33 26 31 22 23
West South Central 60 58 58 49 44 34
West 92 110 87 101 79 84
Mountain 40 42 41 41 36 36
Pacific 83 102 77 93 70 76
COUNTY TYPE            
Large Metro 256 245 186 196 135 137
Small Metro 218 210 150 162 104 101
250K - 1 Mil. Pop. 136 158 92 121 70 76
< 250K Pop. 171 140 116 107 77 64
Nonmetro 104 90 75 58 58 39
Urbanized 83 66 63 45 49 29
Less Urbanized 66 63 42 38 29 24
Completely Rural 28 22 23 15 14 10
130328
Table 1.66D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.51 0.51 0.49 0.49 0.39 0.39
GEOGRAPHIC DIVISION            
Northeast 1.13 1.05 1.16 1.12 0.89 0.92
New England 2.04 2.11 2.18 2.20 1.77 1.87
Middle Atlantic 1.35 1.22 1.38 1.31 1.04 1.06
Midwest 0.95 0.89 0.85 0.82 0.71 0.67
East North Central 1.23 0.97 1.10 0.99 0.92 0.86
West North Central 1.59 1.94 1.38 1.50 1.08 1.01
South 0.91 0.84 0.84 0.79 0.66 0.56
South Atlantic 1.33 1.26 1.20 1.23 0.98 0.88
East South Central 1.80 1.65 1.31 1.55 1.07 1.12
West South Central 1.45 1.37 1.39 1.17 1.06 0.80
West 1.12 1.32 1.05 1.21 0.96 1.01
Mountain 1.61 1.67 1.66 1.63 1.47 1.45
Pacific 1.44 1.74 1.33 1.59 1.21 1.30
COUNTY TYPE            
Large Metro 0.72 0.72 0.70 0.69 0.57 0.57
Small Metro 0.94 0.95 0.84 0.92 0.66 0.66
250K - 1 Mil. Pop. 1.05 1.17 0.99 1.17 0.79 0.86
< 250K Pop. 1.73 1.64 1.51 1.52 1.15 0.96
Nonmetro 1.13 1.11 1.13 0.94 0.97 0.68
Urbanized 1.52 1.72 1.69 1.50 1.59 1.09
Less Urbanized 1.72 1.68 1.46 1.36 1.09 0.91
Completely Rural 3.93 3.35 3.81 2.57 2.56 1.84
130328
Table 1.66P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6576   0.2881   0.6027  
GEOGRAPHIC DIVISION            
Northeast 0.0623   0.0761   0.5002  
New England 0.4344   0.6111   0.9179  
Middle Atlantic 0.0917   0.0845   0.4678  
Midwest 0.8404   0.8971   0.6741  
East North Central 0.7773   0.7778   0.5445  
West North Central 0.9620   0.8313   0.0536  
South 0.8751   0.5762   0.4720  
South Atlantic 0.3177   0.6742   0.5391  
East South Central 0.7609   0.7483   0.4238  
West South Central 0.1753   0.1307   0.9844  
West 0.6971   0.9725   0.7249  
Mountain 0.6692   0.8208   0.9586  
Pacific 0.8207   0.9387   0.7092  
COUNTY TYPE            
Large Metro 0.2219   0.2523   0.8186  
Small Metro 0.8685   0.3774   0.6850  
250K - 1 Mil. Pop. 0.3202   0.7464   0.2890  
< 250K Pop. 0.3582   0.0381   0.4706  
Nonmetro 0.2244   0.2735   0.0808  
Urbanized 0.1190   0.2681   0.0754  
Less Urbanized 0.8901   0.8745   0.5555  
Completely Rural 0.4300   0.4867   0.6470  
130328
Table 1.67C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 993 967 462 488 374 392
GEOGRAPHIC DIVISION            
Northeast 430 381 199 215 162 166
New England 190 175 98 96 82 81
Middle Atlantic 386 336 173 193 139 144
Midwest 371 354 168 182 137 127
East North Central 319 291 144 157 121 109
West North Central 199 220 82 98 60 65
South 592 610 266 265 193 214
South Atlantic 458 486 200 209 142 175
East South Central 213 205 96 93 88 61
West South Central 304 302 153 133 107 103
West 527 521 265 285 217 248
Mountain 231 244 106 124 77 94
Pacific 470 460 242 254 201 227
COUNTY TYPE            
Large Metro 1,112 1,063 387 396 309 307
Small Metro 725 787 257 299 195 241
250K - 1 Mil. Pop. 619 657 210 255 159 207
< 250K Pop. 431 472 137 162 101 133
Nonmetro 477 514 162 149 118 115
Urbanized 320 362 123 112 84 95
Less Urbanized 336 322 98 98 76 65
Completely Rural 131 212 30 38 21 25
130328
Table 1.67D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.50 0.48 0.23 0.24 0.19 0.20
GEOGRAPHIC DIVISION            
Northeast 1.18 1.04 0.54 0.59 0.44 0.45
New England 1.98 1.81 1.02 0.99 0.85 0.84
Middle Atlantic 1.44 1.24 0.64 0.71 0.52 0.53
Midwest 0.86 0.82 0.39 0.42 0.32 0.30
East North Central 1.07 0.97 0.48 0.52 0.41 0.36
West North Central 1.52 1.67 0.63 0.74 0.46 0.49
South 0.81 0.82 0.36 0.36 0.26 0.29
South Atlantic 1.17 1.22 0.51 0.53 0.36 0.44
East South Central 1.80 1.72 0.81 0.78 0.74 0.51
West South Central 1.36 1.33 0.68 0.58 0.48 0.45
West 1.16 1.13 0.58 0.62 0.48 0.54
Mountain 1.66 1.73 0.76 0.88 0.56 0.66
Pacific 1.48 1.43 0.76 0.79 0.63 0.71
COUNTY TYPE            
Large Metro 0.74 0.70 0.34 0.35 0.28 0.28
Small Metro 0.78 0.81 0.39 0.47 0.30 0.38
250K - 1 Mil. Pop. 0.97 0.94 0.47 0.58 0.37 0.48
< 250K Pop. 1.35 1.50 0.63 0.78 0.49 0.66
Nonmetro 1.07 1.11 0.47 0.43 0.35 0.34
Urbanized 1.63 1.72 0.83 0.73 0.63 0.62
Less Urbanized 1.50 1.51 0.60 0.61 0.47 0.41
Completely Rural 2.47 3.31 0.95 0.95 0.62 0.64
130328
Table 1.67P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0921   0.0265   0.0961  
GEOGRAPHIC DIVISION            
Northeast 0.4974   0.2179   0.6435  
New England 0.0589   0.3044   0.1714  
Middle Atlantic 0.8477   0.3946   0.7919  
Midwest 0.0999   0.1979   0.9329  
East North Central 0.0413   0.2018   0.7096  
West North Central 0.8127   0.7055   0.5970  
South 0.9565   0.5333   0.5271  
South Atlantic 0.5494   0.3433   0.0828  
East South Central 0.3309   0.5793   0.0878  
West South Central 0.7128   0.8449   0.8810  
West 0.1027   0.1367   0.0543  
Mountain 0.1661   0.0804   0.1235  
Pacific 0.2510   0.3823   0.1367  
COUNTY TYPE            
Large Metro 0.9503   0.4394   0.7236  
Small Metro 0.0016   0.0069   0.0272  
250K - 1 Mil. Pop. 0.0074   0.0296   0.0795  
< 250K Pop. 0.0847   0.0936   0.1725  
Nonmetro 0.4279   0.5099   0.5170  
Urbanized 0.3322   0.4105   0.1851  
Less Urbanized 0.8977   0.8362   0.5591  
Completely Rural 0.9450   0.7051   0.6735  
130328
Table 1.68C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 1,019 1,002 503 549 403 426
GEOGRAPHIC DIVISION            
Northeast 441 392 222 243 176 181
New England 193 177 111 103 88 91
Middle Atlantic 396 349 193 220 153 157
Midwest 384 367 186 207 152 139
East North Central 331 298 158 167 133 117
West North Central 204 229 92 123 68 75
South 605 630 299 302 218 231
South Atlantic 468 500 236 241 170 192
East South Central 213 213 98 100 88 67
West South Central 318 316 160 154 115 113
West 550 538 288 316 237 270
Mountain 240 244 119 136 89 103
Pacific 491 478 264 283 219 247
COUNTY TYPE            
Large Metro 1,179 1,129 439 460 342 348
Small Metro 786 847 308 349 225 264
250K - 1 Mil. Pop. 658 696 234 283 176 218
< 250K Pop. 485 529 192 215 132 160
Nonmetro 514 552 187 166 136 123
Urbanized 354 390 144 126 101 101
Less Urbanized 364 349 114 108 88 70
Completely Rural 149 224 40 42 26 29
130328
Table 1.68D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.44 0.43 0.22 0.23 0.17 0.18
GEOGRAPHIC DIVISION            
Northeast 1.03 0.91 0.52 0.57 0.41 0.42
New England 1.72 1.57 0.99 0.91 0.79 0.80
Middle Atlantic 1.26 1.10 0.61 0.70 0.49 0.50
Midwest 0.76 0.73 0.37 0.41 0.30 0.28
East North Central 0.95 0.85 0.45 0.48 0.38 0.33
West North Central 1.33 1.48 0.60 0.80 0.44 0.49
South 0.70 0.72 0.35 0.35 0.25 0.27
South Atlantic 1.03 1.08 0.52 0.52 0.37 0.42
East South Central 1.54 1.53 0.71 0.72 0.63 0.48
West South Central 1.20 1.17 0.60 0.57 0.43 0.42
West 1.02 0.99 0.54 0.58 0.44 0.49
Mountain 1.47 1.48 0.73 0.82 0.54 0.62
Pacific 1.31 1.26 0.70 0.75 0.58 0.65
COUNTY TYPE            
Large Metro 0.64 0.61 0.32 0.34 0.26 0.26
Small Metro 0.69 0.71 0.38 0.45 0.29 0.35
250K - 1 Mil. Pop. 0.87 0.83 0.44 0.55 0.35 0.43
< 250K Pop. 1.17 1.31 0.69 0.81 0.50 0.62
Nonmetro 0.97 0.99 0.46 0.40 0.35 0.31
Urbanized 1.45 1.52 0.79 0.70 0.62 0.57
Less Urbanized 1.36 1.37 0.59 0.56 0.46 0.38
Completely Rural 2.35 3.06 0.98 0.91 0.65 0.63
130328
Table 1.68P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0874   0.0213   0.1799  
GEOGRAPHIC DIVISION            
Northeast 0.3469   0.1104   0.5326  
New England 0.0461   0.2644   0.1994  
Middle Atlantic 0.9481   0.2198   0.9924  
Midwest 0.1037   0.2729   0.8182  
East North Central 0.0414   0.2747   0.8851  
West North Central 0.8129   0.7147   0.8352  
South 0.9336   0.4574   0.7481  
South Atlantic 0.6848   0.4827   0.1806  
East South Central 0.3093   0.6693   0.0616  
West South Central 0.9096   0.5158   0.8786  
West 0.1314   0.1856   0.1055  
Mountain 0.1893   0.0956   0.1778  
Pacific 0.2883   0.4599   0.2197  
COUNTY TYPE            
Large Metro 0.8710   0.2549   0.6466  
Small Metro 0.0026   0.0089   0.0595  
250K - 1 Mil. Pop. 0.0162   0.0648   0.1835  
< 250K Pop. 0.0609   0.0468   0.1665  
Nonmetro 0.5731   0.8944   0.9507  
Urbanized 0.5208   0.9070   0.6254  
Less Urbanized 0.8606   0.7905   0.5423  
Completely Rural 0.8495   0.4629   0.4903  
130328
Table 1.69C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 701 703 168 217 106 142
GEOGRAPHIC DIVISION            
Northeast 324 268 86 95 53 58
New England 149 117 34 31 17 22
Middle Atlantic 289 240 80 89 50 54
Midwest 232 264 59 75 39 51
East North Central 200 224 52 68 38 44
West North Central 123 143 27 31 11 25
South 420 431 95 143 59 97
South Atlantic 329 349 71 125 37 88
East South Central 157 142 32 37 19 28
West South Central 197 197 55 53 42 28
West 417 392 91 122 57 72
Mountain 196 159 39 57 22 30
Pacific 365 358 82 107 52 65
COUNTY TYPE            
Large Metro 627 654 143 188 90 124
Small Metro 450 447 85 122 53 69
250K - 1 Mil. Pop. 380 376 69 105 42 59
< 250K Pop. 237 275 49 59 32 35
Nonmetro 260 229 45 42 22 27
Urbanized 173 160 37 24 20 17
Less Urbanized 170 161 23 30 8 13
Completely Rural 84 60 9 18 6 16
130328
Table 1.69D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.27 0.27 0.07 0.08 0.04 0.05
GEOGRAPHIC DIVISION            
Northeast 0.69 0.57 0.18 0.20 0.11 0.12
New England 1.21 0.94 0.27 0.25 0.14 0.18
Middle Atlantic 0.83 0.69 0.23 0.26 0.14 0.16
Midwest 0.42 0.47 0.11 0.13 0.07 0.09
East North Central 0.52 0.58 0.13 0.18 0.10 0.11
West North Central 0.72 0.84 0.16 0.18 0.06 0.15
South 0.44 0.45 0.10 0.15 0.06 0.10
South Atlantic 0.65 0.69 0.14 0.25 0.07 0.17
East South Central 1.02 0.92 0.21 0.24 0.12 0.18
West South Central 0.66 0.65 0.19 0.17 0.14 0.09
West 0.70 0.65 0.15 0.20 0.09 0.12
Mountain 1.08 0.86 0.22 0.31 0.12 0.16
Pacific 0.88 0.85 0.20 0.25 0.13 0.15
COUNTY TYPE            
Large Metro 0.40 0.40 0.10 0.13 0.07 0.09
Small Metro 0.47 0.48 0.10 0.15 0.07 0.09
250K - 1 Mil. Pop. 0.57 0.59 0.13 0.19 0.08 0.11
< 250K Pop. 0.76 0.88 0.18 0.23 0.12 0.14
Nonmetro 0.56 0.50 0.11 0.10 0.05 0.06
Urbanized 0.86 0.79 0.23 0.13 0.12 0.09
Less Urbanized 0.74 0.75 0.12 0.15 0.04 0.07
Completely Rural 1.68 1.06 0.21 0.37 0.14 0.33
130328
Table 1.69P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6718   0.0049   0.1269  
GEOGRAPHIC DIVISION            
Northeast 0.9878   0.3790   0.7533  
New England 0.4680   0.9022   0.3405  
Middle Atlantic 0.7092   0.3274   0.9827  
Midwest 0.3746   0.9000   0.7722  
East North Central 0.3551   0.9231   0.9219  
West North Central 0.8868   0.9285   0.6342  
South 0.7765   0.0189   0.1242  
South Atlantic 0.9247   0.0239   0.0628  
East South Central 0.0708   0.4308   0.4466  
West South Central 0.4971   0.6172   0.6161  
West 0.6324   0.0732   0.5377  
Mountain 0.9164   0.0747   0.4938  
Pacific 0.6291   0.2879   0.7325  
COUNTY TYPE            
Large Metro 0.6923   0.0371   0.1504  
Small Metro 0.3962   0.0507   0.6123  
250K - 1 Mil. Pop. 0.9130   0.0361   0.5091  
< 250K Pop. 0.1799   0.7054   0.9181  
Nonmetro 0.4174   0.8796   0.7864  
Urbanized 0.6905   0.2167   0.6297  
Less Urbanized 0.5398   0.1828   0.7548  
Completely Rural 0.0143   0.3865   0.3558  
130328
Table 1.70C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 26 23 20 19 12 7
GEOGRAPHIC DIVISION            
Northeast 9 8 9 7 4 3
New England 6 3 7 3 4 0
Middle Atlantic 7 7 5 7 2 3
Midwest 9 6 7 5 5 3
East North Central 8 6 7 4 5 3
West North Central 4 2 3 2 2 1
South 17 15 11 13 6 5
South Atlantic 14 7 7 7 4 1
East South Central 5 6 4 5 1 3
West South Central 9 12 8 10 3 4
West 16 14 13 12 8 3
Mountain 5 8 4 6 3 0
Pacific 15 12 12 10 7 3
COUNTY TYPE            
Large Metro 19 18 15 16 10 5
Small Metro 18 12 12 11 6 4
250K - 1 Mil. Pop. 16 11 11 9 5 3
< 250K Pop. 7 6 5 6 1 3
Nonmetro 7 7 6 5 3 2
Urbanized 6 5 4 3 1 2
Less Urbanized 4 5 4 3 3 1
Completely Rural 2 * 1 * * *
130328
Table 1.70D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.11 0.09 0.08 0.08 0.05 0.03
GEOGRAPHIC DIVISION            
Northeast 0.22 0.19 0.20 0.17 0.10 0.07
New England 0.56 0.30 0.60 0.26 0.36 0.04
Middle Atlantic 0.21 0.23 0.16 0.21 0.06 0.09
Midwest 0.17 0.11 0.14 0.09 0.10 0.05
East North Central 0.21 0.15 0.18 0.11 0.13 0.07
West North Central 0.26 0.15 0.17 0.14 0.09 0.05
South 0.19 0.16 0.12 0.14 0.06 0.05
South Atlantic 0.29 0.15 0.15 0.15 0.09 0.03
East South Central 0.31 0.38 0.29 0.34 0.10 0.23
West South Central 0.30 0.37 0.24 0.32 0.10 0.11
West 0.27 0.24 0.21 0.20 0.13 0.05
Mountain 0.27 0.40 0.23 0.33 0.17 0.01
Pacific 0.37 0.29 0.29 0.24 0.17 0.07
COUNTY TYPE            
Large Metro 0.14 0.14 0.11 0.11 0.07 0.04
Small Metro 0.22 0.16 0.15 0.14 0.07 0.05
250K - 1 Mil. Pop. 0.30 0.20 0.19 0.17 0.10 0.06
< 250K Pop. 0.28 0.27 0.22 0.26 0.04 0.11
Nonmetro 0.20 0.18 0.15 0.12 0.08 0.06
Urbanized 0.37 0.25 0.26 0.17 0.06 0.11
Less Urbanized 0.24 0.28 0.21 0.15 0.14 0.08
Completely Rural 0.57 * 0.35 * * *
130328
Table 1.70P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0336   0.0658   0.0037  
GEOGRAPHIC DIVISION            
Northeast 0.1580   0.1917   0.4167  
New England 0.0298   0.0632   0.1059  
Middle Atlantic 0.8034   0.8995   0.5191  
Midwest 0.0578   0.0109   0.0327  
East North Central 0.2149   0.0118   0.0414  
West North Central 0.0738   0.5051   0.5276  
South 0.6950   0.6240   0.7139  
South Atlantic 0.1050   0.4495   0.2173  
East South Central 0.6140   0.6091   0.4892  
West South Central 0.3889   0.3296   0.9554  
West 0.2168   0.1901   0.0143  
Mountain 0.3251   0.7591   0.0753  
Pacific 0.0650   0.0997   0.0629  
COUNTY TYPE            
Large Metro 0.3132   0.3132   0.0092  
Small Metro 0.0506   0.2323   0.3141  
250K - 1 Mil. Pop. 0.0830   0.2480   0.1553  
< 250K Pop. 0.3551   0.6606   0.4964  
Nonmetro 0.5378   0.2268   0.3483  
Urbanized 0.2901   0.1348   0.6261  
Less Urbanized 0.4503   0.7653   0.2563  
Completely Rural *   *   *  
130328
Table 1.71C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 108 113 72 74 41 33
GEOGRAPHIC DIVISION            
Northeast 40 42 27 30 16 14
New England 23 21 15 10 6 7
Middle Atlantic 33 36 23 28 14 13
Midwest 42 44 24 23 15 12
East North Central 34 35 19 21 11 11
West North Central 24 26 16 10 11 4
South 64 65 41 42 23 21
South Atlantic 44 52 31 35 18 18
East South Central 26 19 11 11 6 7
West South Central 38 35 24 19 12 7
West 69 70 48 49 27 20
Mountain 33 32 22 22 10 8
Pacific 60 62 42 44 25 18
COUNTY TYPE            
Large Metro 90 104 57 68 31 29
Small Metro 72 67 48 40 28 17
250K - 1 Mil. Pop. 60 56 41 34 21 15
< 250K Pop. 43 38 25 19 18 9
Nonmetro 42 33 22 15 8 6
Urbanized 34 24 18 11 7 5
Less Urbanized 24 23 11 9 5 3
Completely Rural 10 9 6 4 2 3
130328
Table 1.71D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.32 0.33 0.21 0.21 0.12 0.09
GEOGRAPHIC DIVISION            
Northeast 0.65 0.68 0.44 0.48 0.25 0.23
New England 1.42 1.27 0.92 0.64 0.38 0.40
Middle Atlantic 0.73 0.80 0.50 0.61 0.32 0.28
Midwest 0.57 0.60 0.33 0.31 0.21 0.16
East North Central 0.67 0.70 0.38 0.41 0.21 0.22
West North Central 1.06 1.12 0.70 0.45 0.48 0.16
South 0.51 0.51 0.33 0.33 0.18 0.16
South Atlantic 0.69 0.79 0.49 0.54 0.28 0.27
East South Central 1.31 0.93 0.55 0.52 0.31 0.35
West South Central 0.92 0.84 0.59 0.46 0.29 0.17
West 0.84 0.84 0.58 0.59 0.33 0.24
Mountain 1.33 1.27 0.88 0.88 0.39 0.31
Pacific 1.05 1.06 0.73 0.76 0.44 0.31
COUNTY TYPE            
Large Metro 0.45 0.49 0.29 0.34 0.17 0.15
Small Metro 0.56 0.54 0.39 0.34 0.24 0.15
250K - 1 Mil. Pop. 0.74 0.69 0.54 0.46 0.29 0.20
< 250K Pop. 0.87 0.86 0.48 0.46 0.38 0.22
Nonmetro 0.76 0.64 0.43 0.31 0.17 0.13
Urbanized 1.28 0.97 0.76 0.49 0.29 0.21
Less Urbanized 0.99 0.92 0.49 0.42 0.23 0.13
Completely Rural 2.08 1.79 1.33 0.87 0.40 0.61
130328
Table 1.71P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.8919   0.8186   0.1569  
GEOGRAPHIC DIVISION            
Northeast 0.6094   0.5681   0.7007  
New England 0.2401   0.4805   0.4622  
Middle Atlantic 0.2080   0.3184   0.4220  
Midwest 0.5031   0.0400   0.1266  
East North Central 0.9501   0.0907   0.5429  
West North Central 0.1876   0.2544   0.0874  
South 0.3321   0.4128   0.9845  
South Atlantic 0.1444   0.2703   0.6216  
East South Central 0.2191   0.7579   0.8014  
West South Central 0.5228   0.8072   0.2884  
West 0.3003   0.7737   0.2742  
Mountain 0.9208   0.8365   0.9071  
Pacific 0.2590   0.6717   0.2102  
COUNTY TYPE            
Large Metro 0.2880   0.2899   0.6047  
Small Metro 0.2186   0.5393   0.1508  
250K - 1 Mil. Pop. 0.1021   0.3077   0.2418  
< 250K Pop. 0.8419   0.6510   0.3653  
Nonmetro 0.3539   0.1883   0.3131  
Urbanized 0.2357   0.1812   0.2613  
Less Urbanized 0.8205   0.9356   0.5561  
Completely Rural 0.4632   0.3537   0.5164  
130328
Table 1.72C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 704 683 154 200 96 138
GEOGRAPHIC DIVISION            
Northeast 318 264 82 84 50 57
New England 145 116 28 30 16 21
Middle Atlantic 284 235 76 79 47 53
Midwest 227 259 54 71 38 50
East North Central 193 223 47 63 36 42
West North Central 122 139 25 30 11 25
South 417 421 83 134 54 93
South Atlantic 324 341 60 118 31 85
East South Central 156 137 29 36 18 26
West South Central 194 193 51 49 41 27
West 419 382 83 112 49 69
Mountain 201 156 32 52 20 29
Pacific 365 349 76 98 44 63
COUNTY TYPE            
Large Metro 617 636 132 172 83 120
Small Metro 440 430 72 113 44 66
250K - 1 Mil. Pop. 369 364 58 98 35 57
< 250K Pop. 230 261 42 55 27 34
Nonmetro 251 222 33 39 20 25
Urbanized 167 154 26 21 19 16
Less Urbanized 164 157 20 28 6 12
Completely Rural 80 58 6 18 6 16
130328
Table 1.72D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.35 0.34 0.08 0.10 0.05 0.07
GEOGRAPHIC DIVISION            
Northeast 0.87 0.72 0.22 0.23 0.14 0.15
New England 1.51 1.20 0.30 0.31 0.16 0.21
Middle Atlantic 1.06 0.87 0.28 0.29 0.18 0.19
Midwest 0.53 0.60 0.13 0.16 0.09 0.11
East North Central 0.65 0.74 0.16 0.21 0.12 0.14
West North Central 0.93 1.05 0.19 0.23 0.09 0.19
South 0.57 0.57 0.11 0.18 0.07 0.13
South Atlantic 0.83 0.86 0.15 0.30 0.08 0.21
East South Central 1.32 1.15 0.24 0.31 0.15 0.22
West South Central 0.87 0.85 0.23 0.22 0.18 0.12
West 0.92 0.82 0.18 0.24 0.11 0.15
Mountain 1.45 1.11 0.23 0.37 0.15 0.21
Pacific 1.15 1.08 0.24 0.31 0.14 0.19
COUNTY TYPE            
Large Metro 0.53 0.51 0.12 0.16 0.08 0.11
Small Metro 0.60 0.61 0.12 0.18 0.07 0.11
250K - 1 Mil. Pop. 0.72 0.75 0.14 0.23 0.08 0.14
< 250K Pop. 1.00 1.12 0.21 0.28 0.14 0.17
Nonmetro 0.71 0.62 0.11 0.12 0.06 0.08
Urbanized 1.10 1.00 0.20 0.14 0.15 0.11
Less Urbanized 0.91 0.94 0.13 0.18 0.04 0.08
Completely Rural 2.00 1.28 0.19 0.44 0.16 0.40
130328
Table 1.72P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6334   0.0015   0.0238  
GEOGRAPHIC DIVISION            
Northeast 0.9394   0.3757   0.6320  
New England 0.3109   0.6124   0.3115  
Middle Atlantic 0.5658   0.4508   0.8846  
Midwest 0.2862   0.3942   0.3330  
East North Central 0.3398   0.4789   0.6362  
West North Central 0.6588   0.5961   0.2043  
South 0.6559   0.0280   0.0980  
South Atlantic 0.9289   0.0337   0.0610  
East South Central 0.0899   0.5056   0.5194  
West South Central 0.6027   0.6329   0.8343  
West 0.5030   0.0453   0.1873  
Mountain 0.9390   0.0322   0.3848  
Pacific 0.4733   0.2570   0.2993  
COUNTY TYPE            
Large Metro 0.7788   0.0541   0.0658  
Small Metro 0.2800   0.0123   0.2616  
250K - 1 Mil. Pop. 0.6693   0.0053   0.2432  
< 250K Pop. 0.1962   0.7546   0.8121  
Nonmetro 0.4886   0.2912   0.4546  
Urbanized 0.5516   0.6490   0.8871  
Less Urbanized 0.4834   0.1600   0.3945  
Completely Rural 0.0160   0.1698   0.3621  
130328
Table 1.73C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 704 699 167 217 106 142
GEOGRAPHIC DIVISION            
Northeast 325 268 86 95 52 58
New England 149 117 33 32 17 22
Middle Atlantic 290 240 79 89 49 54
Midwest 233 264 58 75 39 51
East North Central 201 225 52 68 38 44
West North Central 123 142 27 31 10 25
South 420 430 95 142 59 97
South Atlantic 328 349 71 124 36 88
East South Central 157 141 31 37 19 27
West South Central 197 196 55 52 42 28
West 419 390 90 122 56 72
Mountain 198 158 40 57 23 30
Pacific 366 357 81 107 52 65
COUNTY TYPE            
Large Metro 626 654 142 188 89 124
Small Metro 449 445 85 121 52 69
250K - 1 Mil. Pop. 379 373 68 104 41 59
< 250K Pop. 237 274 49 59 32 35
Nonmetro 260 228 45 42 22 27
Urbanized 174 160 38 24 20 17
Less Urbanized 170 161 23 30 7 13
Completely Rural 84 59 9 18 6 16
130328
Table 1.73D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.30 0.30 0.07 0.09 0.05 0.06
GEOGRAPHIC DIVISION            
Northeast 0.76 0.62 0.20 0.22 0.12 0.14
New England 1.33 1.04 0.29 0.28 0.15 0.19
Middle Atlantic 0.92 0.76 0.25 0.28 0.16 0.17
Midwest 0.46 0.52 0.12 0.15 0.08 0.10
East North Central 0.58 0.64 0.15 0.19 0.11 0.13
West North Central 0.80 0.92 0.18 0.20 0.07 0.16
South 0.49 0.49 0.11 0.16 0.07 0.11
South Atlantic 0.72 0.76 0.16 0.27 0.08 0.19
East South Central 1.13 1.02 0.23 0.26 0.14 0.20
West South Central 0.74 0.73 0.21 0.19 0.16 0.10
West 0.78 0.71 0.17 0.22 0.10 0.13
Mountain 1.22 0.96 0.24 0.34 0.14 0.18
Pacific 0.97 0.94 0.22 0.28 0.14 0.17
COUNTY TYPE            
Large Metro 0.45 0.44 0.11 0.15 0.07 0.10
Small Metro 0.52 0.53 0.12 0.17 0.07 0.10
250K - 1 Mil. Pop. 0.63 0.65 0.14 0.21 0.08 0.12
< 250K Pop. 0.85 0.96 0.20 0.25 0.13 0.15
Nonmetro 0.63 0.55 0.12 0.11 0.06 0.07
Urbanized 0.97 0.88 0.25 0.14 0.13 0.10
Less Urbanized 0.82 0.82 0.13 0.17 0.04 0.07
Completely Rural 1.83 1.15 0.23 0.40 0.15 0.37
130328
Table 1.73P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6506   0.0028   0.0819  
GEOGRAPHIC DIVISION            
Northeast 1.0000   0.3246   0.7160  
New England 0.4341   0.8644   0.2337  
Middle Atlantic 0.7018   0.3259   0.9553  
Midwest 0.3534   0.9221   0.6290  
East North Central 0.3442   0.9001   0.7686  
West North Central 0.8530   0.9736   0.5948  
South 0.7766   0.0208   0.1155  
South Atlantic 0.8908   0.0207   0.0546  
East South Central 0.0662   0.4688   0.4891  
West South Central 0.5265   0.7311   0.6110  
West 0.6229   0.0527   0.4106  
Mountain 0.9503   0.0840   0.4094  
Pacific 0.6027   0.2134   0.6173  
COUNTY TYPE            
Large Metro 0.6625   0.0293   0.1034  
Small Metro 0.3893   0.0373   0.5623  
250K - 1 Mil. Pop. 0.8839   0.0256   0.4343  
< 250K Pop. 0.1926   0.6819   0.8750  
Nonmetro 0.4133   0.7749   0.7073  
Urbanized 0.6863   0.2824   0.6010  
Less Urbanized 0.5076   0.1654   0.5754  
Completely Rural 0.0146   0.3980   0.3141  
130328
Table 1.74C – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 327 346 69 111 42 94
GEOGRAPHIC DIVISION            
Northeast 114 143 32 38 22 31
New England 50 46 14 10 12 8
Middle Atlantic 102 135 28 37 19 30
Midwest 125 136 33 44 24 33
East North Central 112 104 30 43 22 32
West North Central 55 87 14 10 9 5
South 201 225 43 95 26 81
South Atlantic 155 177 30 87 21 79
East South Central 83 82 24 16 6 15
West South Central 94 111 19 34 14 11
West 195 180 28 25 5 12
Mountain 75 90 7 19 4 12
Pacific 181 157 27 17 4 4
COUNTY TYPE            
Large Metro 267 273 49 92 26 79
Small Metro 173 205 44 61 29 47
250K - 1 Mil. Pop. 133 169 32 52 23 46
< 250K Pop. 100 116 30 32 17 9
Nonmetro 118 109 27 31 16 18
Urbanized 75 71 19 16 15 14
Less Urbanized 90 77 18 22 2 6
Completely Rural 21 39 6 16 6 9
130328
Table 1.74D – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.13 0.13 0.03 0.04 0.02 0.04
GEOGRAPHIC DIVISION            
Northeast 0.24 0.30 0.07 0.08 0.05 0.07
New England 0.41 0.37 0.12 0.08 0.10 0.07
Middle Atlantic 0.30 0.39 0.08 0.11 0.05 0.09
Midwest 0.22 0.24 0.06 0.08 0.04 0.06
East North Central 0.29 0.27 0.08 0.11 0.06 0.08
West North Central 0.32 0.51 0.08 0.06 0.05 0.03
South 0.21 0.23 0.05 0.10 0.03 0.08
South Atlantic 0.31 0.35 0.06 0.17 0.04 0.16
East South Central 0.54 0.53 0.16 0.10 0.04 0.10
West South Central 0.32 0.37 0.06 0.11 0.05 0.04
West 0.33 0.30 0.05 0.04 0.01 0.02
Mountain 0.41 0.49 0.04 0.10 0.02 0.06
Pacific 0.44 0.37 0.06 0.04 0.01 0.01
COUNTY TYPE            
Large Metro 0.19 0.19 0.04 0.07 0.02 0.06
Small Metro 0.20 0.25 0.05 0.08 0.04 0.06
250K - 1 Mil. Pop. 0.23 0.31 0.06 0.10 0.04 0.09
< 250K Pop. 0.35 0.42 0.11 0.12 0.06 0.04
Nonmetro 0.27 0.25 0.07 0.07 0.04 0.04
Urbanized 0.41 0.37 0.11 0.09 0.09 0.08
Less Urbanized 0.43 0.38 0.09 0.11 0.01 0.03
Completely Rural 0.51 0.78 0.14 0.34 0.14 0.20
130328
Table 1.74P – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.1175   0.0321   0.0405  
GEOGRAPHIC DIVISION            
Northeast 0.7095   0.4486   0.5724  
New England 0.5334   0.2843   0.5473  
Middle Atlantic 0.8835   0.2301   0.3972  
Midwest 0.3289   0.7605   0.8456  
East North Central 0.5899   0.6566   0.7843  
West North Central 0.3347   0.6794   0.7939  
South 0.0906   0.0300   0.0558  
South Atlantic 0.2260   0.0516   0.0685  
East South Central 0.5879   0.7619   0.0890  
West South Central 0.2697   0.1578   0.4712  
West 0.6989   0.8990   0.1675  
Mountain 0.2467   0.1159   0.1186  
Pacific 0.8950   0.3976   0.9370  
COUNTY TYPE            
Large Metro 0.4366   0.0704   0.0365  
Small Metro 0.0416   0.4531   0.6636  
250K - 1 Mil. Pop. 0.2116   0.3785   0.4701  
< 250K Pop. 0.0723   0.9541   0.4758  
Nonmetro 0.6669   0.3325   0.5600  
Urbanized 0.6837   0.8174   0.7648  
Less Urbanized 0.6732   0.3209   0.3845  
Completely Rural 0.5438   0.2957   0.9133  
130328
Table 1.75C – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 628 674 143 175 60 90
GEOGRAPHIC DIVISION            
Northeast 267 274 55 62 26 27
New England 141 127 29 29 17 11
Middle Atlantic 226 241 47 55 19 25
Midwest 242 249 52 51 25 36
East North Central 209 201 43 47 20 34
West North Central 128 155 30 18 15 9
South 373 380 84 100 33 63
South Atlantic 268 297 70 88 22 60
East South Central 127 133 19 25 14 8
West South Central 202 186 40 41 20 17
West 374 397 90 116 36 49
Mountain 191 184 37 47 20 20
Pacific 321 353 83 106 30 45
COUNTY TYPE            
Large Metro 546 592 118 141 49 66
Small Metro 390 443 78 105 29 64
250K - 1 Mil. Pop. 325 376 64 78 25 57
< 250K Pop. 229 238 45 70 15 28
Nonmetro 241 249 36 36 20 13
Urbanized 172 185 27 27 11 6
Less Urbanized 163 154 24 21 17 9
Completely Rural 73 66 6 12 3 6
130328
Table 1.75D – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.24 0.26 0.06 0.07 0.02 0.03
GEOGRAPHIC DIVISION            
Northeast 0.57 0.58 0.12 0.13 0.05 0.06
New England 1.15 1.03 0.24 0.23 0.14 0.09
Middle Atlantic 0.65 0.69 0.14 0.16 0.06 0.07
Midwest 0.43 0.45 0.09 0.09 0.05 0.06
East North Central 0.54 0.52 0.11 0.12 0.05 0.09
West North Central 0.75 0.90 0.17 0.11 0.09 0.05
South 0.39 0.39 0.09 0.10 0.03 0.07
South Atlantic 0.53 0.58 0.14 0.17 0.04 0.12
East South Central 0.83 0.87 0.13 0.16 0.09 0.05
West South Central 0.68 0.62 0.13 0.14 0.07 0.06
West 0.63 0.65 0.15 0.19 0.06 0.08
Mountain 1.05 1.00 0.20 0.25 0.11 0.11
Pacific 0.77 0.84 0.20 0.25 0.07 0.11
COUNTY TYPE            
Large Metro 0.36 0.37 0.09 0.10 0.04 0.05
Small Metro 0.42 0.46 0.10 0.13 0.04 0.08
250K - 1 Mil. Pop. 0.51 0.57 0.12 0.14 0.05 0.11
< 250K Pop. 0.74 0.78 0.17 0.26 0.06 0.11
Nonmetro 0.49 0.51 0.09 0.08 0.05 0.03
Urbanized 0.78 0.87 0.16 0.14 0.06 0.03
Less Urbanized 0.71 0.71 0.13 0.11 0.09 0.05
Completely Rural 1.40 1.13 0.14 0.25 0.08 0.12
130328
Table 1.75P – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.1960   0.3911   0.1576  
GEOGRAPHIC DIVISION            
Northeast 0.4799   0.7522   0.7122  
New England 0.0850   0.4505   0.4513  
Middle Atlantic 0.8346   0.4389   0.3296  
Midwest 0.4033   0.5171   0.1945  
East North Central 0.3337   0.5362   0.0523  
West North Central 0.9461   0.0170   0.2854  
South 0.9259   0.0757   0.0890  
South Atlantic 0.2427   0.0390   0.0071  
East South Central 0.0993   0.3659   0.2111  
West South Central 0.4674   0.6349   0.2379  
West 0.2161   0.9262   0.5181  
Mountain 0.4275   0.2558   0.6160  
Pacific 0.3284   0.5850   0.6429  
COUNTY TYPE            
Large Metro 0.3376   0.3981   0.5009  
Small Metro 0.1210   0.4274   0.0776  
250K - 1 Mil. Pop. 0.2231   0.8339   0.3163  
< 250K Pop. 0.3302   0.0920   0.0530  
Nonmetro 0.5367   0.3884   0.3352  
Urbanized 0.5943   0.2007   0.1018  
Less Urbanized 0.3681   0.6685   0.7106  
Completely Rural 0.1183   0.1899   0.3949  
130328
Table 1.76C – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 491 489 107 120 68 65
GEOGRAPHIC DIVISION            
Northeast 257 202 41 35 23 10
New England 111 94 20 16 12 5
Middle Atlantic 232 177 35 31 19 9
Midwest 165 175 40 29 30 17
East North Central 140 147 23 27 10 15
West North Central 93 97 33 12 28 9
South 287 304 45 76 34 35
South Atlantic 220 251 38 69 29 30
East South Central 86 104 12 14 7 7
West South Central 152 145 22 29 16 17
West 279 282 76 77 46 49
Mountain 149 141 43 28 23 10
Pacific 236 242 63 72 39 48
COUNTY TYPE            
Large Metro 417 414 75 91 43 61
Small Metro 278 322 75 49 51 16
250K - 1 Mil. Pop. 253 258 65 44 47 12
< 250K Pop. 125 198 36 21 21 12
Nonmetro 142 161 17 63 9 12
Urbanized 101 135 15 61 10 5
Less Urbanized 97 92 12 12 7 7
Completely Rural 28 50 4 9 1 7
130328
Table 1.76D – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.19 0.19 0.04 0.05 0.03 0.02
GEOGRAPHIC DIVISION            
Northeast 0.55 0.43 0.09 0.07 0.05 0.02
New England 0.90 0.76 0.16 0.13 0.10 0.04
Middle Atlantic 0.67 0.51 0.10 0.09 0.06 0.03
Midwest 0.30 0.31 0.07 0.05 0.05 0.03
East North Central 0.36 0.38 0.06 0.07 0.03 0.04
West North Central 0.55 0.57 0.19 0.07 0.17 0.05
South 0.30 0.32 0.05 0.08 0.04 0.04
South Atlantic 0.44 0.49 0.08 0.14 0.06 0.06
East South Central 0.56 0.68 0.08 0.09 0.05 0.04
West South Central 0.51 0.48 0.07 0.10 0.06 0.06
West 0.47 0.47 0.13 0.13 0.08 0.08
Mountain 0.82 0.77 0.24 0.15 0.13 0.05
Pacific 0.57 0.57 0.15 0.17 0.09 0.11
COUNTY TYPE            
Large Metro 0.29 0.27 0.05 0.06 0.03 0.04
Small Metro 0.31 0.36 0.09 0.06 0.06 0.02
250K - 1 Mil. Pop. 0.40 0.43 0.12 0.08 0.09 0.02
< 250K Pop. 0.47 0.67 0.14 0.08 0.08 0.05
Nonmetro 0.33 0.36 0.04 0.15 0.02 0.03
Urbanized 0.55 0.67 0.09 0.33 0.06 0.03
Less Urbanized 0.45 0.46 0.06 0.06 0.03 0.04
Completely Rural 0.65 0.96 0.09 0.19 0.02 0.15
130328
Table 1.76P – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.5982   0.2371   0.1275  
GEOGRAPHIC DIVISION            
Northeast 0.1531   0.0974   0.0064  
New England 0.9003   0.2195   0.0904  
Middle Atlantic 0.0966   0.2250   0.0302  
Midwest 0.4598   0.2570   0.6196  
East North Central 0.4893   0.7137   0.2657  
West North Central 0.7731   0.0457   0.2108  
South 0.2649   0.4690   0.6634  
South Atlantic 0.0616   0.4999   0.5624  
East South Central 0.8359   0.7504   0.6576  
West South Central 0.5063   0.8955   0.7837  
West 0.6447   0.3138   0.6241  
Mountain 0.1417   0.1141   0.3910  
Pacific 0.7357   0.7897   0.8655  
COUNTY TYPE            
Large Metro 0.5556   0.9660   0.6587  
Small Metro 0.1379   0.0118   0.0019  
250K - 1 Mil. Pop. 0.8587   0.0310   0.0027  
< 250K Pop. 0.0179   0.1819   0.3650  
Nonmetro 0.3615   0.4834   0.5291  
Urbanized 0.1767   0.4455   0.0819  
Less Urbanized 0.8797   0.3563   0.8305  
Completely Rural 0.8024   0.2558   0.1427  
130328
Table 1.77C – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 58 51 40 34 20 19
GEOGRAPHIC DIVISION            
Northeast 22 20 18 11 8 4
New England 9 9 6 5 3 2
Middle Atlantic 20 18 17 10 8 3
Midwest 23 20 15 13 7 7
East North Central 17 17 10 11 5 5
West North Central 14 11 10 7 4 5
South 32 33 20 21 11 13
South Atlantic 22 24 14 15 7 7
East South Central 11 12 8 9 6 6
West South Central 20 20 12 12 6 9
West 37 31 27 20 13 12
Mountain 15 13 12 7 3 5
Pacific 34 28 23 18 12 10
COUNTY TYPE            
Large Metro 52 46 34 29 15 16
Small Metro 31 28 20 16 11 8
250K - 1 Mil. Pop. 25 22 18 13 10 7
< 250K Pop. 19 18 10 10 4 5
Nonmetro 23 20 13 12 8 7
Urbanized 15 14 9 9 5 4
Less Urbanized 18 13 9 7 6 5
Completely Rural 6 6 3 4 1 3
130328
Table 1.77D – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.23 0.21 0.16 0.14 0.08 0.08
GEOGRAPHIC DIVISION            
Northeast 0.52 0.48 0.43 0.25 0.19 0.09
New England 0.79 0.82 0.58 0.42 0.28 0.16
Middle Atlantic 0.64 0.59 0.54 0.31 0.24 0.11
Midwest 0.42 0.37 0.27 0.24 0.12 0.13
East North Central 0.46 0.45 0.27 0.30 0.13 0.14
West North Central 0.87 0.68 0.60 0.42 0.27 0.29
South 0.34 0.35 0.21 0.23 0.12 0.14
South Atlantic 0.48 0.51 0.29 0.32 0.16 0.16
East South Central 0.73 0.82 0.56 0.59 0.38 0.37
West South Central 0.65 0.61 0.39 0.39 0.20 0.28
West 0.62 0.51 0.44 0.33 0.21 0.19
Mountain 0.81 0.73 0.67 0.40 0.17 0.26
Pacific 0.82 0.68 0.56 0.45 0.29 0.25
COUNTY TYPE            
Large Metro 0.35 0.31 0.25 0.21 0.11 0.12
Small Metro 0.36 0.35 0.26 0.21 0.14 0.11
250K - 1 Mil. Pop. 0.42 0.40 0.32 0.24 0.19 0.13
< 250K Pop. 0.64 0.65 0.39 0.40 0.16 0.20
Nonmetro 0.54 0.47 0.32 0.30 0.21 0.18
Urbanized 0.79 0.65 0.50 0.47 0.32 0.19
Less Urbanized 0.88 0.76 0.49 0.43 0.34 0.31
Completely Rural 1.63 1.54 0.75 1.03 0.26 0.79
130328
Table 1.77P – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0006   0.0011   0.2050  
GEOGRAPHIC DIVISION            
Northeast 0.1802   0.0031   0.0115  
New England 0.2328   0.0338   0.1772  
Middle Atlantic 0.3592   0.0191   0.0296  
Midwest 0.0511   0.2515   0.9706  
East North Central 0.4008   0.7667   0.6407  
West North Central 0.0324   0.0301   0.6685  
South 0.3730   0.9764   0.7312  
South Atlantic 0.8994   0.3939   0.8180  
East South Central 0.9558   0.6223   0.6355  
West South Central 0.1233   0.5581   0.2798  
West 0.0096   0.0103   0.3178  
Mountain 0.2439   0.0766   0.4421  
Pacific 0.0215   0.0457   0.1862  
COUNTY TYPE            
Large Metro 0.0139   0.0293   0.7867  
Small Metro 0.1476   0.0360   0.0120  
250K - 1 Mil. Pop. 0.0391   0.0042   0.0063  
< 250K Pop. 0.7891   0.6153   0.9117  
Nonmetro 0.0481   0.1679   0.5437  
Urbanized 0.5437   0.1592   0.2155  
Less Urbanized 0.0736   0.3935   0.8129  
Completely Rural 0.5091   0.5649   0.2283  
130328
Table 1.78C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 752 765 363 406 231 265
GEOGRAPHIC DIVISION            
Northeast 321 297 139 151 91 96
New England 147 117 66 64 42 41
Middle Atlantic 284 272 122 137 81 86
Midwest 273 282 133 157 95 85
East North Central 223 242 115 135 83 72
West North Central 158 152 70 80 49 43
South 447 464 234 250 130 168
South Atlantic 354 346 183 179 95 113
East South Central 164 172 87 97 56 64
West South Central 231 250 114 138 76 102
West 437 431 202 222 135 152
Mountain 195 200 93 95 53 59
Pacific 391 380 181 203 124 141
COUNTY TYPE            
Large Metro 702 771 290 347 174 222
Small Metro 494 513 209 212 132 131
250K - 1 Mil. Pop. 414 440 164 171 108 114
< 250K Pop. 300 278 130 134 76 66
Nonmetro 334 304 146 161 93 73
Urbanized 252 220 117 119 69 50
Less Urbanized 205 196 82 105 59 48
Completely Rural 110 116 35 34 25 23
130328
Table 1.78D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.29 0.29 0.14 0.16 0.09 0.10
GEOGRAPHIC DIVISION            
Northeast 0.69 0.63 0.30 0.32 0.19 0.20
New England 1.20 0.94 0.54 0.52 0.34 0.33
Middle Atlantic 0.82 0.78 0.35 0.39 0.24 0.25
Midwest 0.49 0.50 0.24 0.28 0.17 0.15
East North Central 0.58 0.62 0.30 0.35 0.21 0.19
West North Central 0.93 0.89 0.41 0.47 0.29 0.25
South 0.47 0.48 0.25 0.26 0.14 0.17
South Atlantic 0.71 0.68 0.36 0.35 0.19 0.22
East South Central 1.07 1.12 0.57 0.63 0.37 0.41
West South Central 0.78 0.83 0.39 0.46 0.25 0.34
West 0.73 0.71 0.34 0.37 0.22 0.25
Mountain 1.07 1.09 0.51 0.51 0.29 0.32
Pacific 0.94 0.90 0.43 0.48 0.30 0.33
COUNTY TYPE            
Large Metro 0.44 0.44 0.21 0.23 0.13 0.16
Small Metro 0.46 0.49 0.24 0.25 0.16 0.16
250K - 1 Mil. Pop. 0.57 0.62 0.28 0.31 0.20 0.21
< 250K Pop. 0.81 0.78 0.47 0.45 0.28 0.24
Nonmetro 0.66 0.59 0.32 0.35 0.22 0.17
Urbanized 1.08 1.00 0.58 0.61 0.36 0.27
Less Urbanized 0.80 0.78 0.40 0.48 0.30 0.24
Completely Rural 1.96 1.87 0.78 0.66 0.57 0.46
130328
Table 1.78P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0121   0.0004   0.0593  
GEOGRAPHIC DIVISION            
Northeast 0.2175   0.2099   0.9917  
New England 0.2443   0.9120   0.9531  
Middle Atlantic 0.4297   0.1468   0.9699  
Midwest 0.4280   0.3149   0.4541  
East North Central 0.1326   0.2582   0.9711  
West North Central 0.3789   0.9261   0.1628  
South 0.5333   0.0319   0.0159  
South Atlantic 0.4569   0.3343   0.0623  
East South Central 0.4811   0.3104   0.3794  
West South Central 0.5507   0.0610   0.2017  
West 0.0185   0.0149   0.2010  
Mountain 0.5688   0.4178   0.3869  
Pacific 0.0178   0.0230   0.3020  
COUNTY TYPE            
Large Metro 0.0027   0.0001   0.0044  
Small Metro 0.3538   0.3190   0.7545  
250K - 1 Mil. Pop. 0.6360   0.2305   0.3690  
< 250K Pop. 0.3120   0.9716   0.3495  
Nonmetro 0.3952   0.9814   0.1355  
Urbanized 0.7288   0.3361   0.0947  
Less Urbanized 0.7066   0.2066   0.7612  
Completely Rural 0.1962   0.9019   0.6809  
130328
Table 1.79C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 64 64 53 53 35 37
GEOGRAPHIC DIVISION            
Northeast 24 22 19 19 14 11
New England 10 11 9 9 6 5
Middle Atlantic 22 19 17 17 12 9
Midwest 26 24 21 21 15 13
East North Central 20 20 17 17 12 11
West North Central 16 13 13 12 8 8
South 39 43 33 34 21 26
South Atlantic 26 30 22 24 15 19
East South Central 15 14 13 12 7 8
West South Central 24 26 20 21 13 15
West 37 38 32 31 19 19
Mountain 18 17 13 16 9 9
Pacific 33 34 29 26 17 17
COUNTY TYPE            
Large Metro 56 56 43 47 26 32
Small Metro 41 36 35 28 21 18
250K - 1 Mil. Pop. 31 31 27 24 16 15
< 250K Pop. 26 22 20 16 14 10
Nonmetro 27 26 22 19 13 12
Urbanized 20 20 17 14 9 9
Less Urbanized 21 15 15 11 9 6
Completely Rural 8 8 6 7 3 5
130328
Table 1.79D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.26 0.26 0.21 0.21 0.14 0.15
GEOGRAPHIC DIVISION            
Northeast 0.57 0.52 0.45 0.46 0.32 0.26
New England 0.94 1.01 0.77 0.85 0.57 0.49
Middle Atlantic 0.69 0.61 0.54 0.54 0.38 0.30
Midwest 0.47 0.44 0.38 0.38 0.27 0.24
East North Central 0.53 0.54 0.44 0.46 0.32 0.28
West North Central 0.99 0.80 0.78 0.72 0.51 0.48
South 0.42 0.46 0.35 0.37 0.23 0.28
South Atlantic 0.56 0.65 0.48 0.52 0.33 0.41
East South Central 1.05 0.98 0.90 0.81 0.49 0.57
West South Central 0.77 0.81 0.63 0.65 0.40 0.49
West 0.62 0.63 0.53 0.52 0.32 0.33
Mountain 0.97 0.90 0.72 0.86 0.47 0.48
Pacific 0.79 0.82 0.70 0.64 0.42 0.42
COUNTY TYPE            
Large Metro 0.37 0.37 0.29 0.32 0.19 0.22
Small Metro 0.47 0.44 0.40 0.36 0.26 0.23
250K - 1 Mil. Pop. 0.54 0.53 0.47 0.44 0.29 0.27
< 250K Pop. 0.86 0.82 0.71 0.63 0.53 0.43
Nonmetro 0.60 0.59 0.52 0.46 0.33 0.29
Urbanized 0.94 0.91 0.82 0.70 0.50 0.46
Less Urbanized 0.94 0.82 0.73 0.64 0.48 0.38
Completely Rural 1.99 1.71 1.48 1.56 0.96 1.11
130328
Table 1.79P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6854   0.1606   0.9119  
GEOGRAPHIC DIVISION            
Northeast 0.1349   0.0638   0.4169  
New England 0.3442   0.6771   0.8103  
Middle Atlantic 0.2350   0.0585   0.2857  
Midwest 0.4375   0.3485   0.3140  
East North Central 0.7229   0.6371   0.5000  
West North Central 0.0873   0.3754   0.4550  
South 0.5111   0.7074   0.6176  
South Atlantic 0.1929   0.6223   0.3244  
East South Central 0.6405   0.5802   0.2589  
West South Central 0.9000   0.3739   0.8004  
West 0.9808   0.7475   0.4144  
Mountain 0.4778   0.1936   0.2524  
Pacific 0.6818   0.3100   0.7252  
COUNTY TYPE            
Large Metro 0.3686   0.2886   0.4594  
Small Metro 0.4117   0.6691   0.5438  
250K - 1 Mil. Pop. 0.6685   0.6952   0.7687  
< 250K Pop. 0.3781   0.8527   0.5270  
Nonmetro 0.6767   0.3921   0.7594  
Urbanized 0.4067   0.6409   0.7967  
Less Urbanized 0.1558   0.2976   0.7779  
Completely Rural 0.8179   0.6250   0.8867  
130328
Table 1.80C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 145 151 110 111 69 74
GEOGRAPHIC DIVISION            
Northeast 53 62 39 47 26 38
New England 25 33 20 24 13 21
Middle Atlantic 47 53 34 40 22 32
Midwest 58 59 41 45 27 27
East North Central 49 46 35 34 23 24
West North Central 31 39 24 30 14 12
South 93 97 68 66 44 43
South Atlantic 65 70 50 52 32 33
East South Central 36 33 25 21 21 15
West South Central 53 55 38 33 23 22
West 81 85 60 66 39 39
Mountain 41 36 29 25 20 15
Pacific 70 77 52 61 33 36
COUNTY TYPE            
Large Metro 141 170 93 111 53 66
Small Metro 129 130 77 82 49 39
250K - 1 Mil. Pop. 93 87 59 56 36 29
< 250K Pop. 91 96 50 61 32 25
Nonmetro 72 57 49 35 25 21
Urbanized 61 43 41 23 18 13
Less Urbanized 40 38 27 24 17 16
Completely Rural 21 17 8 11 4 6
130328
Table 1.80D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.42 0.44 0.32 0.32 0.20 0.21
GEOGRAPHIC DIVISION            
Northeast 0.86 1.02 0.64 0.76 0.42 0.62
New England 1.53 2.03 1.26 1.48 0.80 1.28
Middle Atlantic 1.03 1.18 0.75 0.89 0.49 0.71
Midwest 0.78 0.81 0.57 0.61 0.36 0.36
East North Central 0.97 0.91 0.69 0.67 0.46 0.47
West North Central 1.35 1.72 1.05 1.31 0.62 0.53
South 0.73 0.76 0.54 0.52 0.35 0.33
South Atlantic 1.01 1.07 0.78 0.80 0.50 0.50
East South Central 1.79 1.65 1.23 1.05 1.02 0.75
West South Central 1.27 1.31 0.92 0.78 0.56 0.53
West 0.99 1.02 0.73 0.79 0.47 0.46
Mountain 1.68 1.43 1.16 1.00 0.81 0.61
Pacific 1.22 1.32 0.89 1.04 0.58 0.62
COUNTY TYPE            
Large Metro 0.59 0.65 0.44 0.47 0.27 0.33
Small Metro 0.77 0.74 0.55 0.56 0.38 0.32
250K - 1 Mil. Pop. 0.98 0.84 0.73 0.66 0.47 0.40
< 250K Pop. 1.16 1.42 0.84 1.07 0.63 0.54
Nonmetro 1.02 0.91 0.84 0.64 0.46 0.42
Urbanized 1.67 1.42 1.43 0.89 0.71 0.56
Less Urbanized 1.29 1.34 1.08 0.96 0.71 0.70
Completely Rural 3.53 2.78 1.61 2.18 0.89 1.25
130328
Table 1.80P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.2126   0.0320   0.2813  
GEOGRAPHIC DIVISION            
Northeast 0.0329   0.0466   0.0985  
New England 0.3436   0.7986   0.5861  
Middle Atlantic 0.0552   0.0275   0.1169  
Midwest 0.6730   0.7371   0.0927  
East North Central 0.6180   0.8447   0.4143  
West North Central 0.9801   0.7644   0.0459  
South 0.7856   0.1866   0.2067  
South Atlantic 0.7644   0.1295   0.1838  
East South Central 0.1787   0.3606   0.7497  
West South Central 0.2591   0.3111   0.4585  
West 0.9420   0.2175   0.6819  
Mountain 0.3722   0.1721   0.8921  
Pacific 0.5750   0.0422   0.6961  
COUNTY TYPE            
Large Metro 0.0038   0.0007   0.0672  
Small Metro 0.3673   0.9131   0.6304  
250K - 1 Mil. Pop. 0.1815   0.7971   0.7202  
< 250K Pop. 0.8565   0.6245   0.2139  
Nonmetro 0.1850   0.1059   0.7457  
Urbanized 0.1136   0.0250   0.2620  
Less Urbanized 0.7067   0.7283   0.7657  
Completely Rural 0.6881   0.2851   0.5462  
130328
Table 1.81C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 740 740 338 380 215 247
GEOGRAPHIC DIVISION            
Northeast 316 288 129 137 85 87
New England 143 116 61 57 38 36
Middle Atlantic 281 263 114 124 76 79
Midwest 261 268 124 148 89 78
East North Central 211 231 108 128 77 66
West North Central 154 142 65 71 47 37
South 437 444 214 236 119 161
South Atlantic 347 331 169 169 85 108
East South Central 156 167 78 92 49 60
West South Central 221 236 106 132 69 98
West 434 423 187 209 128 143
Mountain 188 194 84 88 48 54
Pacific 390 374 168 190 119 132
COUNTY TYPE            
Large Metro 671 730 266 317 160 207
Small Metro 457 464 181 185 118 121
250K - 1 Mil. Pop. 392 408 144 152 102 105
< 250K Pop. 264 234 109 110 60 59
Nonmetro 307 281 131 150 89 65
Urbanized 236 201 106 111 67 45
Less Urbanized 179 180 71 96 53 41
Completely Rural 96 104 30 29 24 20
130328
Table 1.81D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.37 0.37 0.17 0.19 0.11 0.12
GEOGRAPHIC DIVISION            
Northeast 0.87 0.78 0.35 0.37 0.23 0.24
New England 1.49 1.19 0.64 0.59 0.40 0.37
Middle Atlantic 1.04 0.97 0.43 0.46 0.28 0.29
Midwest 0.61 0.62 0.29 0.34 0.21 0.18
East North Central 0.71 0.77 0.36 0.43 0.26 0.22
West North Central 1.18 1.07 0.50 0.54 0.36 0.28
South 0.60 0.60 0.29 0.32 0.16 0.22
South Atlantic 0.89 0.83 0.43 0.43 0.22 0.27
East South Central 1.32 1.40 0.66 0.77 0.41 0.51
West South Central 0.99 1.04 0.47 0.58 0.31 0.43
West 0.95 0.91 0.41 0.45 0.28 0.31
Mountain 1.35 1.38 0.61 0.63 0.35 0.38
Pacific 1.23 1.16 0.53 0.59 0.37 0.41
COUNTY TYPE            
Large Metro 0.56 0.56 0.25 0.28 0.15 0.19
Small Metro 0.59 0.61 0.28 0.30 0.19 0.20
250K - 1 Mil. Pop. 0.72 0.77 0.33 0.36 0.24 0.25
< 250K Pop. 1.04 0.97 0.55 0.53 0.31 0.30
Nonmetro 0.80 0.72 0.38 0.43 0.27 0.19
Urbanized 1.39 1.21 0.73 0.74 0.47 0.32
Less Urbanized 0.95 0.97 0.44 0.59 0.35 0.26
Completely Rural 2.18 2.14 0.85 0.73 0.69 0.51
130328
Table 1.81P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0206   0.0009   0.0991  
GEOGRAPHIC DIVISION            
Northeast 0.3473   0.3268   0.6216  
New England 0.3058   0.8692   0.7418  
Middle Atlantic 0.6014   0.2433   0.6964  
Midwest 0.4302   0.1857   0.9204  
East North Central 0.1560   0.1856   0.7332  
West North Central 0.4507   0.7008   0.4562  
South 0.6117   0.0512   0.0371  
South Atlantic 0.5691   0.6406   0.1774  
East South Central 0.7150   0.1311   0.2036  
West South Central 0.6989   0.0606   0.2703  
West 0.0191   0.0223   0.2660  
Mountain 0.4868   0.2722   0.5020  
Pacific 0.0227   0.0470   0.3519  
COUNTY TYPE            
Large Metro 0.0102   0.0014   0.0206  
Small Metro 0.3029   0.2481   0.5419  
250K - 1 Mil. Pop. 0.4913   0.1390   0.3746  
< 250K Pop. 0.3806   0.9620   0.7318  
Nonmetro 0.5799   0.5054   0.1613  
Urbanized 0.9707   0.8093   0.1764  
Less Urbanized 0.8081   0.1190   0.6622  
Completely Rural 0.1521   0.6383   0.5763  
130328
Table 1.82C – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 752 759 357 398 228 263
GEOGRAPHIC DIVISION            
Northeast 322 293 136 149 89 95
New England 147 114 66 64 42 41
Middle Atlantic 286 269 120 135 80 85
Midwest 270 280 131 155 94 84
East North Central 221 241 113 133 82 72
West North Central 154 149 69 78 48 41
South 444 458 228 244 128 166
South Atlantic 351 343 179 177 93 111
East South Central 163 171 85 95 56 63
West South Central 230 245 111 134 73 101
West 439 430 198 219 133 152
Mountain 192 198 90 93 52 58
Pacific 393 380 178 200 123 140
COUNTY TYPE            
Large Metro 695 761 285 338 170 218
Small Metro 487 505 201 209 130 130
250K - 1 Mil. Pop. 411 432 158 168 107 113
< 250K Pop. 290 272 124 130 74 64
Nonmetro 325 298 138 158 91 71
Urbanized 245 215 110 116 68 48
Less Urbanized 197 194 78 104 58 48
Completely Rural 107 112 34 31 24 21
130328
Table 1.82D – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.32 0.32 0.15 0.17 0.10 0.11
GEOGRAPHIC DIVISION            
Northeast 0.76 0.68 0.32 0.35 0.21 0.22
New England 1.31 1.01 0.58 0.57 0.37 0.36
Middle Atlantic 0.91 0.85 0.38 0.43 0.25 0.27
Midwest 0.54 0.55 0.26 0.31 0.19 0.17
East North Central 0.63 0.69 0.32 0.38 0.24 0.21
West North Central 1.00 0.96 0.45 0.50 0.31 0.26
South 0.52 0.53 0.27 0.28 0.15 0.19
South Atlantic 0.77 0.74 0.39 0.38 0.20 0.24
East South Central 1.18 1.23 0.62 0.68 0.41 0.45
West South Central 0.87 0.91 0.42 0.50 0.28 0.37
West 0.81 0.79 0.37 0.40 0.25 0.28
Mountain 1.18 1.20 0.55 0.56 0.32 0.35
Pacific 1.05 1.00 0.47 0.53 0.33 0.37
COUNTY TYPE            
Large Metro 0.48 0.48 0.23 0.25 0.14 0.17
Small Metro 0.51 0.54 0.26 0.28 0.18 0.18
250K - 1 Mil. Pop. 0.62 0.68 0.30 0.34 0.21 0.23
< 250K Pop. 0.89 0.85 0.50 0.49 0.30 0.26
Nonmetro 0.72 0.64 0.34 0.38 0.24 0.18
Urbanized 1.19 1.08 0.63 0.66 0.41 0.29
Less Urbanized 0.88 0.86 0.42 0.53 0.33 0.26
Completely Rural 2.10 1.98 0.84 0.68 0.61 0.46
130328
Table 1.82P – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0117   0.0002   0.0592  
GEOGRAPHIC DIVISION            
Northeast 0.1830   0.1368   0.9052  
New England 0.2153   0.9563   0.9208  
Middle Atlantic 0.3880   0.0922   0.8618  
Midwest 0.3936   0.2553   0.5531  
East North Central 0.1423   0.2308   0.9498  
West North Central 0.4622   0.8098   0.1908  
South 0.5795   0.0237   0.0173  
South Atlantic 0.5323   0.3600   0.0826  
East South Central 0.5023   0.2646   0.2912  
West South Central 0.5397   0.0366   0.2066  
West 0.0189   0.0112   0.2404  
Mountain 0.6130   0.5465   0.4874  
Pacific 0.0168   0.0132   0.3233  
COUNTY TYPE            
Large Metro 0.0020   0.0001   0.0055  
Small Metro 0.4246   0.2773   0.6792  
250K - 1 Mil. Pop. 0.6856   0.1970   0.3433  
< 250K Pop. 0.3803   0.9449   0.4038  
Nonmetro 0.3987   0.8793   0.1436  
Urbanized 0.6520   0.3526   0.0996  
Less Urbanized 0.7995   0.1483   0.7970  
Completely Rural 0.1955   0.8279   0.6543  
130328
Table 1.83C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 598 622 302 355 189 211
GEOGRAPHIC DIVISION            
Northeast 236 241 123 126 78 82
New England 124 103 57 51 40 29
Middle Atlantic 200 216 109 115 67 77
Midwest 229 245 124 145 85 77
East North Central 194 206 106 126 76 64
West North Central 124 133 63 68 41 41
South 376 377 197 215 104 132
South Atlantic 291 272 153 156 75 94
East South Central 124 150 70 88 43 55
West South Central 211 195 104 112 63 73
West 339 342 155 188 106 110
Mountain 153 157 73 82 45 49
Pacific 305 304 135 170 97 100
COUNTY TYPE            
Large Metro 497 573 242 297 137 174
Small Metro 374 389 179 176 116 99
250K - 1 Mil. Pop. 310 326 144 139 98 81
< 250K Pop. 233 223 105 107 63 56
Nonmetro 257 230 108 146 75 63
Urbanized 194 177 81 111 55 34
Less Urbanized 157 143 65 92 46 47
Completely Rural 82 74 28 29 25 23
130328
Table 1.83D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.23 0.24 0.12 0.14 0.07 0.08
GEOGRAPHIC DIVISION            
Northeast 0.50 0.51 0.26 0.27 0.17 0.17
New England 1.01 0.83 0.46 0.41 0.32 0.23
Middle Atlantic 0.58 0.62 0.32 0.33 0.19 0.22
Midwest 0.41 0.44 0.22 0.26 0.15 0.14
East North Central 0.50 0.53 0.28 0.32 0.20 0.16
West North Central 0.73 0.78 0.37 0.40 0.24 0.24
South 0.39 0.39 0.21 0.22 0.11 0.14
South Atlantic 0.58 0.53 0.30 0.31 0.15 0.18
East South Central 0.81 0.97 0.46 0.57 0.28 0.35
West South Central 0.71 0.65 0.35 0.37 0.21 0.24
West 0.57 0.57 0.26 0.31 0.18 0.18
Mountain 0.84 0.85 0.40 0.44 0.25 0.26
Pacific 0.73 0.72 0.32 0.40 0.23 0.24
COUNTY TYPE            
Large Metro 0.33 0.35 0.17 0.20 0.10 0.12
Small Metro 0.40 0.41 0.20 0.21 0.14 0.12
250K - 1 Mil. Pop. 0.48 0.52 0.24 0.25 0.18 0.15
< 250K Pop. 0.72 0.66 0.38 0.36 0.23 0.21
Nonmetro 0.54 0.47 0.25 0.33 0.18 0.14
Urbanized 0.89 0.83 0.46 0.57 0.31 0.18
Less Urbanized 0.68 0.59 0.32 0.44 0.24 0.24
Completely Rural 1.69 1.30 0.64 0.56 0.57 0.45
130328
Table 1.83P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0038   0.0069   0.2255  
GEOGRAPHIC DIVISION            
Northeast 0.0579   0.7292   0.9283  
New England 0.2988   0.6408   0.6035  
Middle Atlantic 0.1102   0.5415   0.7436  
Midwest 0.3713   0.6725   0.5673  
East North Central 0.2096   0.5253   0.5911  
West North Central 0.7924   0.8078   0.8326  
South 0.4748   0.0462   0.0297  
South Atlantic 0.3930   0.0878   0.0080  
East South Central 0.3610   0.3649   0.7364  
West South Central 0.6619   0.5234   0.8222  
West 0.0155   0.0219   0.7858  
Mountain 0.7243   0.6899   0.8559  
Pacific 0.0117   0.0060   0.8294  
COUNTY TYPE            
Large Metro 0.0001   0.0007   0.0127  
Small Metro 0.6239   0.8551   0.4870  
250K - 1 Mil. Pop. 0.8030   0.9694   0.7388  
< 250K Pop. 0.5943   0.7912   0.4444  
Nonmetro 0.5091   0.6285   0.2890  
Urbanized 0.8617   0.8318   0.0809  
Less Urbanized 0.5452   0.3095   0.6884  
Completely Rural 0.5086   0.9529   0.6677  
130328
Table 1.84C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 59 58 48 47 31 32
GEOGRAPHIC DIVISION            
Northeast 23 18 18 16 12 10
New England 10 9 8 7 6 5
Middle Atlantic 21 16 16 14 11 8
Midwest 24 22 20 19 14 12
East North Central 19 19 16 16 11 10
West North Central 15 12 12 11 8 8
South 35 38 29 29 18 21
South Atlantic 23 27 20 20 13 14
East South Central 14 14 12 12 6 8
West South Central 22 23 17 17 10 12
West 36 34 30 30 17 19
Mountain 17 16 13 15 8 9
Pacific 31 31 27 25 15 17
COUNTY TYPE            
Large Metro 52 50 40 41 23 27
Small Metro 38 33 31 26 19 17
250K - 1 Mil. Pop. 30 28 26 22 14 13
< 250K Pop. 22 20 16 15 12 10
Nonmetro 22 24 18 16 12 11
Urbanized 17 18 12 12 9 8
Less Urbanized 18 15 13 10 8 6
Completely Rural 7 6 6 6 3 4
130328
Table 1.84D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.23 0.23 0.19 0.19 0.12 0.13
GEOGRAPHIC DIVISION            
Northeast 0.54 0.43 0.42 0.37 0.29 0.23
New England 0.88 0.79 0.74 0.64 0.55 0.48
Middle Atlantic 0.65 0.51 0.50 0.45 0.34 0.26
Midwest 0.44 0.41 0.36 0.34 0.25 0.23
East North Central 0.49 0.49 0.41 0.41 0.28 0.26
West North Central 0.93 0.74 0.73 0.65 0.51 0.49
South 0.37 0.41 0.31 0.31 0.20 0.23
South Atlantic 0.49 0.59 0.42 0.43 0.28 0.31
East South Central 0.93 0.93 0.82 0.80 0.41 0.53
West South Central 0.68 0.73 0.54 0.53 0.33 0.39
West 0.59 0.58 0.50 0.50 0.29 0.31
Mountain 0.94 0.84 0.72 0.82 0.44 0.46
Pacific 0.75 0.75 0.65 0.62 0.37 0.40
COUNTY TYPE            
Large Metro 0.34 0.33 0.27 0.28 0.17 0.19
Small Metro 0.43 0.41 0.36 0.33 0.24 0.22
250K - 1 Mil. Pop. 0.51 0.49 0.46 0.40 0.27 0.25
< 250K Pop. 0.77 0.77 0.57 0.58 0.45 0.41
Nonmetro 0.53 0.54 0.44 0.39 0.31 0.27
Urbanized 0.84 0.81 0.66 0.60 0.49 0.42
Less Urbanized 0.86 0.79 0.66 0.55 0.44 0.37
Completely Rural 1.68 1.47 1.38 1.28 0.84 0.89
130328
Table 1.84P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.3445   0.0251   0.9311  
GEOGRAPHIC DIVISION            
Northeast 0.0195   0.0052   0.2272  
New England 0.3850   0.4786   0.8499  
Middle Atlantic 0.0287   0.0053   0.1239  
Midwest 0.3309   0.1691   0.2379  
East North Central 0.9265   0.4153   0.5053  
West North Central 0.0933   0.2411   0.2995  
South 0.4207   0.4447   0.4214  
South Atlantic 0.1188   0.7653   0.2328  
East South Central 0.7629   0.2412   0.3357  
West South Central 0.7836   0.3747   0.5646  
West 0.6922   0.6191   0.5523  
Mountain 0.9087   0.2840   0.2404  
Pacific 0.6054   0.2527   0.9474  
COUNTY TYPE            
Large Metro 0.2307   0.0929   0.5987  
Small Metro 0.6527   0.3859   0.6088  
250K - 1 Mil. Pop. 0.8973   0.3224   0.7356  
< 250K Pop. 0.5301   0.9615   0.6736  
Nonmetro 0.4929   0.2547   0.6256  
Urbanized 0.8045   0.4478   0.5574  
Less Urbanized 0.2826   0.3919   0.9473  
Completely Rural 0.6957   0.9349   0.9482  
130328
Table 1.85C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 130 138 94 97 58 65
GEOGRAPHIC DIVISION            
Northeast 45 55 34 38 21 30
New England 25 28 17 14 11 11
Middle Atlantic 38 48 29 36 18 28
Midwest 53 54 36 37 23 24
East North Central 44 44 31 31 21 21
West North Central 31 33 20 20 11 10
South 87 81 58 57 34 40
South Atlantic 63 59 42 43 21 31
East South Central 35 31 24 20 19 14
West South Central 47 45 31 30 18 20
West 71 84 53 61 35 34
Mountain 32 32 28 22 19 13
Pacific 63 77 44 57 30 32
COUNTY TYPE            
Large Metro 119 139 80 88 46 56
Small Metro 110 105 62 63 38 30
250K - 1 Mil. Pop. 77 75 46 48 27 23
< 250K Pop. 79 73 41 41 26 19
Nonmetro 65 51 42 30 21 19
Urbanized 54 37 34 20 15 11
Less Urbanized 35 35 23 21 15 15
Completely Rural 19 16 7 10 4 5
130328
Table 1.85D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.38 0.40 0.27 0.28 0.17 0.19
GEOGRAPHIC DIVISION            
Northeast 0.74 0.90 0.55 0.62 0.35 0.49
New England 1.54 1.76 1.06 0.85 0.71 0.66
Middle Atlantic 0.84 1.06 0.64 0.78 0.40 0.62
Midwest 0.72 0.73 0.49 0.50 0.32 0.32
East North Central 0.86 0.86 0.61 0.61 0.41 0.42
West North Central 1.38 1.44 0.87 0.86 0.47 0.44
South 0.69 0.64 0.46 0.45 0.27 0.31
South Atlantic 0.98 0.90 0.66 0.66 0.32 0.48
East South Central 1.75 1.55 1.21 0.99 0.97 0.67
West South Central 1.14 1.07 0.74 0.71 0.44 0.48
West 0.86 1.01 0.65 0.73 0.43 0.41
Mountain 1.31 1.30 1.12 0.90 0.76 0.52
Pacific 1.10 1.32 0.76 0.98 0.51 0.55
COUNTY TYPE            
Large Metro 0.53 0.60 0.39 0.41 0.24 0.29
Small Metro 0.67 0.64 0.46 0.47 0.31 0.27
250K - 1 Mil. Pop. 0.84 0.80 0.58 0.60 0.36 0.33
< 250K Pop. 1.07 1.09 0.74 0.80 0.55 0.47
Nonmetro 1.00 0.86 0.75 0.57 0.40 0.38
Urbanized 1.62 1.29 1.27 0.79 0.61 0.49
Less Urbanized 1.23 1.29 0.95 0.83 0.63 0.64
Completely Rural 3.47 2.66 1.33 2.05 0.88 1.12
130328
Table 1.85P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.6128   0.3480   0.3641  
GEOGRAPHIC DIVISION            
Northeast 0.1663   0.5287   0.1547  
New England 0.9141   0.4331   0.7232  
Middle Atlantic 0.1200   0.2500   0.1625  
Midwest 0.1751   0.3916   0.1274  
East North Central 0.5808   0.7034   0.4422  
West North Central 0.1334   0.3027   0.0586  
South 0.5526   0.1481   0.0995  
South Atlantic 0.4539   0.1132   0.0150  
East South Central 0.3761   0.5558   0.2704  
West South Central 0.4088   0.3083   0.5156  
West 0.7769   0.7831   0.8710  
Mountain 0.7150   0.1636   0.8371  
Pacific 0.6348   0.3118   0.7673  
COUNTY TYPE            
Large Metro 0.0211   0.0433   0.0850  
Small Metro 0.1199   0.7244   0.5289  
250K - 1 Mil. Pop. 0.0857   0.7011   0.7966  
< 250K Pop. 0.7779   0.9365   0.2128  
Nonmetro 0.2065   0.2403   0.7089  
Urbanized 0.0629   0.0999   0.3936  
Less Urbanized 0.8761   0.7097   0.8931  
Completely Rural 0.5367   0.2926   0.8835  
130328
Table 1.86C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 589 589 280 332 178 199
GEOGRAPHIC DIVISION            
Northeast 227 226 113 114 73 75
New England 116 103 50 49 37 27
Middle Atlantic 194 200 102 103 63 69
Midwest 216 231 114 138 80 71
East North Central 185 196 98 121 71 59
West North Central 117 123 58 60 39 36
South 369 360 179 205 95 127
South Atlantic 284 262 139 149 68 90
East South Central 118 143 63 84 34 52
West South Central 208 186 98 107 60 70
West 337 322 142 175 100 105
Mountain 149 145 65 73 41 46
Pacific 304 287 125 158 92 95
COUNTY TYPE            
Large Metro 473 535 219 274 125 164
Small Metro 342 348 157 158 107 91
250K - 1 Mil. Pop. 294 297 130 123 95 74
< 250K Pop. 199 191 88 97 51 52
Nonmetro 234 211 93 138 69 54
Urbanized 180 161 70 105 50 29
Less Urbanized 140 126 54 85 41 40
Completely Rural 69 64 26 24 24 20
130328
Table 1.86D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.30 0.29 0.14 0.17 0.09 0.10
GEOGRAPHIC DIVISION            
Northeast 0.62 0.61 0.31 0.31 0.20 0.20
New England 1.21 1.07 0.52 0.50 0.39 0.28
Middle Atlantic 0.72 0.74 0.38 0.38 0.23 0.26
Midwest 0.50 0.54 0.27 0.32 0.19 0.16
East North Central 0.62 0.65 0.33 0.40 0.24 0.20
West North Central 0.90 0.93 0.45 0.46 0.30 0.27
South 0.50 0.48 0.24 0.28 0.13 0.17
South Atlantic 0.73 0.66 0.36 0.37 0.17 0.23
East South Central 1.00 1.20 0.53 0.70 0.29 0.44
West South Central 0.93 0.82 0.44 0.47 0.27 0.31
West 0.74 0.70 0.31 0.38 0.22 0.23
Mountain 1.08 1.03 0.47 0.52 0.29 0.33
Pacific 0.96 0.89 0.39 0.49 0.29 0.29
COUNTY TYPE            
Large Metro 0.42 0.44 0.21 0.25 0.12 0.15
Small Metro 0.50 0.50 0.24 0.26 0.17 0.15
250K - 1 Mil. Pop. 0.62 0.63 0.29 0.30 0.22 0.18
< 250K Pop. 0.88 0.82 0.45 0.47 0.26 0.26
Nonmetro 0.65 0.56 0.28 0.40 0.21 0.16
Urbanized 1.12 1.00 0.51 0.70 0.38 0.20
Less Urbanized 0.81 0.70 0.34 0.53 0.26 0.26
Completely Rural 1.84 1.48 0.75 0.61 0.69 0.51
130328
Table 1.86P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0033   0.0030   0.3133  
GEOGRAPHIC DIVISION            
Northeast 0.0619   0.5711   0.8196  
New England 0.2778   0.8897   0.4711  
Middle Atlantic 0.1255   0.4921   0.9456  
Midwest 0.1716   0.3677   0.9417  
East North Central 0.1538   0.3702   0.8313  
West North Central 0.7436   0.7881   0.6199  
South 0.6121   0.0715   0.1030  
South Atlantic 0.5892   0.2060   0.0701  
East South Central 0.2064   0.1727   0.3719  
West South Central 0.5463   0.5921   0.9487  
West 0.0141   0.0124   0.8051  
Mountain 0.6606   0.9099   0.9163  
Pacific 0.0120   0.0044   0.7508  
COUNTY TYPE            
Large Metro 0.0005   0.0013   0.0504  
Small Metro 0.4262   0.9081   0.6891  
250K - 1 Mil. Pop. 0.5430   0.7757   0.7158  
< 250K Pop. 0.5763   0.8583   0.8689  
Nonmetro 0.7846   0.2629   0.3599  
Urbanized 0.7401   0.6498   0.1405  
Less Urbanized 0.5736   0.1897   0.6993  
Completely Rural 0.4404   0.8620   0.6493  
130328
Table 1.87C – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Numbers in Thousands, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 597 614 297 349 187 210
GEOGRAPHIC DIVISION            
Northeast 236 237 120 124 76 82
New England 124 102 55 52 40 29
Middle Atlantic 201 213 107 113 66 76
Midwest 227 242 122 142 85 76
East North Central 193 204 105 124 75 63
West North Central 122 129 62 64 41 38
South 377 372 192 210 103 130
South Atlantic 291 270 150 155 74 93
East South Central 124 149 69 86 42 54
West South Central 211 192 102 109 62 72
West 337 339 151 185 105 110
Mountain 149 156 69 80 44 48
Pacific 304 301 133 167 95 100
COUNTY TYPE            
Large Metro 491 563 236 290 133 172
Small Metro 368 381 172 172 114 98
250K - 1 Mil. Pop. 308 319 139 136 97 80
< 250K Pop. 225 218 100 103 61 55
Nonmetro 253 226 105 144 73 61
Urbanized 191 172 79 109 54 32
Less Urbanized 151 141 62 91 45 46
Completely Rural 80 72 27 27 24 21
130328
Table 1.87D – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Standard Errors of Percentages, 2011 and 2012
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.26 0.26 0.13 0.15 0.08 0.09
GEOGRAPHIC DIVISION            
Northeast 0.55 0.55 0.28 0.29 0.18 0.19
New England 1.10 0.90 0.49 0.46 0.35 0.26
Middle Atlantic 0.64 0.67 0.34 0.36 0.21 0.24
Midwest 0.45 0.48 0.24 0.28 0.17 0.15
East North Central 0.55 0.58 0.30 0.35 0.22 0.18
West North Central 0.80 0.83 0.41 0.41 0.27 0.25
South 0.44 0.43 0.22 0.24 0.12 0.15
South Atlantic 0.64 0.59 0.33 0.34 0.16 0.20
East South Central 0.90 1.07 0.50 0.62 0.31 0.39
West South Central 0.80 0.71 0.38 0.40 0.23 0.27
West 0.63 0.62 0.28 0.34 0.19 0.20
Mountain 0.91 0.94 0.42 0.48 0.27 0.29
Pacific 0.81 0.79 0.36 0.44 0.25 0.26
COUNTY TYPE            
Large Metro 0.36 0.38 0.19 0.22 0.11 0.14
Small Metro 0.43 0.45 0.22 0.23 0.15 0.14
250K - 1 Mil. Pop. 0.54 0.57 0.26 0.28 0.19 0.16
< 250K Pop. 0.78 0.73 0.40 0.39 0.25 0.23
Nonmetro 0.60 0.51 0.27 0.36 0.19 0.15
Urbanized 0.99 0.90 0.50 0.62 0.34 0.19
Less Urbanized 0.74 0.65 0.34 0.48 0.26 0.26
Completely Rural 1.82 1.41 0.68 0.57 0.61 0.46
130328
Table 1.87P – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Geographic Characteristic Lifetime
(2011)
Lifetime
(2012)
Past Year
(2011)
Past Year
(2012)
Past Month
(2011)
Past Month
(2012)
*Low precision; no estimate reported.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL 0.0029   0.0020   0.2154  
GEOGRAPHIC DIVISION            
Northeast 0.0365   0.4823   0.7996  
New England 0.2713   0.7097   0.5779  
Middle Atlantic 0.0744   0.3385   0.6025  
Midwest 0.3232   0.5369   0.7059  
East North Central 0.2126   0.4555   0.6647  
West North Central 0.9324   0.9643   0.9937  
South 0.5301   0.0305   0.0378  
South Atlantic 0.4837   0.0902   0.0125  
East South Central 0.3460   0.2788   0.6363  
West South Central 0.6815   0.4174   0.8934  
West 0.0133   0.0144   0.8565  
Mountain 0.7331   0.5417   0.9771  
Pacific 0.0098   0.0024   0.8340  
COUNTY TYPE            
Large Metro 0.0001   0.0002   0.0144  
Small Metro 0.6766   0.9767   0.5499  
250K - 1 Mil. Pop. 0.8245   0.8875   0.7825  
< 250K Pop. 0.6594   0.8029   0.4949  
Nonmetro 0.5438   0.5071   0.3220  
Urbanized 0.8303   0.9048   0.0938  
Less Urbanized 0.6219   0.2367   0.6698  
Completely Rural 0.5257   0.9481   0.6596  
130329
Table 1.88C – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Standard Errors of Numbers in Thousands, 2011 and 2012
Drug or Method of Administration Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
HALLUCINOGENS 628 674 43 39 121 131 618 641
PCP (Angel Dust, Phencyclidine) 307 311 10 13 32 30 303 309
LSD (Acid) 530 561 19 21 74 87 526 538
Peyote 276 338 8 10 26 31 273 331
Mescaline 324 362 5 7 32 30 322 359
Psilocybin (Mushrooms) 499 524 24 24 96 99 486 502
Ecstasy (MDMA) 367 405 37 30 102 117 344 374
INHALANTS 491 489 58 51 95 84 479 471
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 323 311 23 21 42 40 318 306
Correction Fluid, Degreaser, or Cleaning Fluid 146 162 25 26 29 28 141 157
Gasoline or Lighter Fluid 185 184 31 31 33 40 178 174
Glue, Shoe Polish, or Toluene 197 182 34 31 33 32 190 175
Halothane, Ether, or Other Anesthetics 113 89 13 8 19 15 109 88
Lacquer Thinner or Other Paint Solvents 137 132 22 21 27 21 128 130
Lighter Gases (Butane, Propane) 89 91 16 18 15 16 83 89
Nitrous Oxide or Whippits 364 365 20 18 78 71 352 349
Spray Paints 139 123 35 34 33 28 128 115
Other Aerosol Sprays 138 154 28 24 42 33 126 149
NEEDLE USE1,2,3 218 225 9 10 32 38 216 222
Heroin Needle Use1,2 158 162 7 7 24 28 156 161
Cocaine Needle Use1,2 156 160 4 3 18 20 155 158
Stimulant Needle Use1,2,3 141 143 7 4 21 22 138 139
Methamphetamine Needle Use1,2,3 131 134 6 3 16 21 129 131
HEROIN 227 245 12 12 43 43 223 241
Smoke Heroin2 137 153 10 9 30 30 132 148
Sniff or Snort Heroin2 189 203 9 5 32 35 186 203
130329
Table 1.88D – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Standard Errors of Percentages, 2011 and 2012
Drug or Method of Administration Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
HALLUCINOGENS 0.24 0.26 0.17 0.15 0.35 0.38 0.31 0.32
PCP (Angel Dust, Phencyclidine) 0.12 0.12 0.04 0.05 0.09 0.09 0.15 0.15
LSD (Acid) 0.21 0.22 0.08 0.09 0.22 0.25 0.27 0.27
Peyote 0.11 0.13 0.03 0.04 0.08 0.09 0.14 0.17
Mescaline 0.13 0.14 0.02 0.03 0.09 0.09 0.16 0.18
Psilocybin (Mushrooms) 0.19 0.20 0.10 0.10 0.28 0.29 0.25 0.25
Ecstasy (MDMA) 0.14 0.16 0.15 0.12 0.30 0.34 0.17 0.19
INHALANTS 0.19 0.19 0.23 0.21 0.28 0.24 0.24 0.23
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 0.13 0.12 0.09 0.08 0.12 0.12 0.16 0.15
Correction Fluid, Degreaser, or Cleaning Fluid 0.06 0.06 0.10 0.10 0.08 0.08 0.07 0.08
Gasoline or Lighter Fluid 0.07 0.07 0.12 0.13 0.10 0.12 0.09 0.09
Glue, Shoe Polish, or Toluene 0.08 0.07 0.14 0.13 0.10 0.09 0.10 0.09
Halothane, Ether, or Other Anesthetics 0.04 0.03 0.05 0.03 0.05 0.04 0.05 0.04
Lacquer Thinner or Other Paint Solvents 0.05 0.05 0.09 0.08 0.08 0.06 0.06 0.07
Lighter Gases (Butane, Propane) 0.03 0.04 0.07 0.07 0.04 0.05 0.04 0.04
Nitrous Oxide or Whippits 0.14 0.14 0.08 0.07 0.23 0.21 0.18 0.17
Spray Paints 0.05 0.05 0.14 0.14 0.10 0.08 0.06 0.06
Other Aerosol Sprays 0.05 0.06 0.11 0.10 0.12 0.10 0.06 0.07
NEEDLE USE1,2,3 0.08 0.09 0.04 0.04 0.09 0.11 0.11 0.11
Heroin Needle Use1,2 0.06 0.06 0.03 0.03 0.07 0.08 0.08 0.08
Cocaine Needle Use1,2 0.06 0.06 0.02 0.01 0.05 0.06 0.08 0.08
Stimulant Needle Use1,2,3 0.05 0.05 0.03 0.02 0.06 0.06 0.07 0.07
Methamphetamine Needle Use1,2,3 0.05 0.05 0.02 0.01 0.05 0.06 0.07 0.07
HEROIN 0.09 0.09 0.05 0.05 0.13 0.12 0.11 0.12
Smoke Heroin2 0.05 0.06 0.04 0.04 0.09 0.09 0.07 0.07
Sniff or Snort Heroin2 0.07 0.08 0.04 0.02 0.09 0.10 0.09 0.10
130329
Table 1.88P – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Drug or Method of Administration Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
HALLUCINOGENS 0.1960   0.0620   0.8952   0.1628  
PCP (Angel Dust, Phencyclidine) 0.3638   0.2201   0.8380   0.3821  
LSD (Acid) 0.4995   0.4909   0.8920   0.5179  
Peyote 0.1492   0.8494   0.4386   0.1711  
Mescaline 0.9608   0.5766   0.3266   0.9937  
Psilocybin (Mushrooms) 0.9000   0.5754   0.0326   0.7847  
Ecstasy (MDMA) 0.0089   0.0135   0.2045   0.0085  
INHALANTS 0.5982   0.0006   0.0941   0.2132  
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 0.4342   0.0166   0.0957   0.6711  
Correction Fluid, Degreaser, or Cleaning Fluid 0.4884   0.5949   0.1089   0.7573  
Gasoline or Lighter Fluid 0.8542   0.3204   0.8733   0.7309  
Glue, Shoe Polish, or Toluene 0.3224   0.1674   0.5961   0.5136  
Halothane, Ether, or Other Anesthetics 0.3598   0.0104   0.1624   0.6845  
Lacquer Thinner or Other Paint Solvents 0.2887   0.7393   0.1873   0.4285  
Lighter Gases (Butane, Propane) 0.8139   0.5608   0.4758   0.6173  
Nitrous Oxide or Whippits 0.1298   0.0572   0.3488   0.0636  
Spray Paints 0.0580   0.0377   0.2343   0.2618  
Other Aerosol Sprays 0.7999   0.0364   0.0266   0.4480  
NEEDLE USE1,2,3 0.2492   0.9037   0.1083   0.3653  
Heroin Needle Use1,2 0.3457   0.9927   0.0714   0.5153  
Cocaine Needle Use1,2 0.8207   0.4139   0.5120   0.8751  
Stimulant Needle Use1,2,3 0.3442   0.2177   0.8180   0.2933  
Methamphetamine Needle Use1,2,3 0.2051   0.1664   0.4104   0.2216  
HEROIN 0.2688   0.5558   0.3005   0.3540  
Smoke Heroin2 0.0974   0.5131   0.1612   0.1515  
Sniff or Snort Heroin2 0.3046   0.0919   0.1952   0.3941  
130329
Table 1.89C – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Standard Errors of Numbers in Thousands, 2011 and 2012
Pain Reliever Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Darvocet®, Darvon®, or Tylenol® with Codeine 434 443 38 39 78 88 427 432
Percocet®, Percodan®, or Tylox® 364 390 25 25 90 90 353 375
Vicodin®, Lortab®, or Lorcet® 462 512 40 40 117 118 447 479
Codeine 247 264 26 25 72 74 239 250
Demerol® 155 144 8 9 25 27 153 139
Dilaudid® 84 162 3 4 24 34 80 158
Fioricet® 63 60 6 3 11 12 62 59
Fiorinal® 51 51 6 5 10 11 50 49
Hydrocodone 301 358 29 26 88 94 288 333
Methadone 122 142 17 14 45 45 113 134
Morphine 140 176 19 17 50 55 128 165
OxyContin® 211 245 25 23 74 77 196 228
Phenaphen® with Codeine 66 72 11 10 20 21 62 67
Propoxyphene 46 50 6 9 10 14 45 47
SK-65® 9 12 3 4 8 9 * *
Stadol® 27 33 2 3 1 9 27 32
Talacen® 24 18 3 4 4 8 23 16
Talwin® 47 51 3 6 * 9 47 50
Talwin® NX 28 39 5 2 3 9 28 38
Tramadol 134 157 17 12 45 47 122 146
Ultram® 95 105 7 9 24 24 91 101
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 438 463 43 42 91 102 430 447
Oxycodone Products3 384 409 32 30 97 102 368 395
Hydrocodone Products4 492 535 42 44 120 123 477 498
Tramadol Products5 150 170 18 13 48 49 137 159
130329
Table 1.89D – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Standard Errors of Percentages, 2011 and 2012
Pain Reliever Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Darvocet®, Darvon®, or Tylenol® with Codeine 0.17 0.17 0.15 0.16 0.23 0.25 0.22 0.22
Percocet®, Percodan®, or Tylox® 0.14 0.15 0.10 0.10 0.26 0.26 0.18 0.19
Vicodin®, Lortab®, or Lorcet® 0.18 0.20 0.16 0.16 0.34 0.34 0.23 0.24
Codeine 0.10 0.10 0.11 0.10 0.21 0.21 0.12 0.12
Demerol® 0.06 0.06 0.03 0.03 0.07 0.08 0.08 0.07
Dilaudid® 0.03 0.06 0.01 0.02 0.07 0.10 0.04 0.08
Fioricet® 0.02 0.02 0.03 0.01 0.03 0.03 0.03 0.03
Fiorinal® 0.02 0.02 0.03 0.02 0.03 0.03 0.03 0.02
Hydrocodone 0.12 0.14 0.12 0.10 0.26 0.27 0.15 0.17
Methadone 0.05 0.05 0.07 0.06 0.13 0.13 0.06 0.07
Morphine 0.05 0.07 0.08 0.07 0.15 0.16 0.06 0.08
OxyContin® 0.08 0.09 0.10 0.09 0.22 0.22 0.10 0.11
Phenaphen® with Codeine 0.03 0.03 0.04 0.04 0.06 0.06 0.03 0.03
Propoxyphene 0.02 0.02 0.02 0.04 0.03 0.04 0.02 0.02
SK-65® 0.00 0.00 0.01 0.02 0.02 0.03 * *
Stadol® 0.01 0.01 0.01 0.01 0.00 0.02 0.01 0.02
Talacen® 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.01
Talwin® 0.02 0.02 0.01 0.02 * 0.03 0.02 0.02
Talwin® NX 0.01 0.01 0.02 0.01 0.01 0.02 0.01 0.02
Tramadol 0.05 0.06 0.07 0.05 0.13 0.14 0.06 0.07
Ultram® 0.04 0.04 0.03 0.03 0.07 0.07 0.05 0.05
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 0.17 0.18 0.17 0.17 0.26 0.30 0.22 0.22
Oxycodone Products3 0.15 0.16 0.13 0.12 0.28 0.29 0.19 0.20
Hydrocodone Products4 0.19 0.21 0.17 0.18 0.35 0.36 0.24 0.25
Tramadol Products5 0.06 0.07 0.07 0.05 0.14 0.14 0.07 0.08
130329
Table 1.89P – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Pain Reliever Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Darvocet®, Darvon®, or Tylenol® with Codeine 0.0234   0.2685   0.8856   0.0176  
Percocet®, Percodan®, or Tylox® 0.0358   0.0893   0.5729   0.0154  
Vicodin®, Lortab®, or Lorcet® 0.0009   0.0939   0.9558   0.0003  
Codeine 0.3329   0.3966   0.2881   0.1585  
Demerol® 0.8757   0.9842   0.8159   0.8438  
Dilaudid® 0.0001   0.6132   0.0701   0.0002  
Fioricet® 0.3299   0.1010   0.5931   0.3364  
Fiorinal® 0.7543   0.2811   0.9922   0.6591  
Hydrocodone 0.0010   0.0419   0.3295   0.0009  
Methadone 0.0785   0.0177   0.6367   0.0188  
Morphine 0.0001   0.7353   0.0916   0.0004  
OxyContin® 0.0625   0.1616   0.4363   0.0151  
Phenaphen® with Codeine 0.8339   0.7951   0.6101   0.6655  
Propoxyphene 0.8615   0.3067   0.7435   0.9375  
SK-65® 0.2449   0.1002   0.9729   *  
Stadol® 0.9470   0.6221   0.0880   0.7476  
Talacen® 0.7967   0.4740   0.6249   0.5693  
Talwin® 0.5827   0.2609   *   0.8736  
Talwin® NX 0.1735   0.1630   0.2628   0.1807  
Tramadol 0.0110   0.0078   0.0337   0.0206  
Ultram® 0.3476   0.9886   0.3778   0.2359  
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 0.0284   0.4096   0.7367   0.0166  
Oxycodone Products3 0.0539   0.0634   0.3515   0.0169  
Hydrocodone Products4 0.0018   0.1028   0.9925   0.0007  
Tramadol Products5 0.0093   0.0085   0.0968   0.0111  
130329
Table 1.90C – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Standard Errors of Numbers in Thousands, 2011 and 2012
Tranquilizer Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Klonopin® or Clonazepam 227 240 19 18 64 65 215 228
Xanax®, Alprazolam, Ativan®, or Lorazepam 373 423 31 32 95 104 358 393
Valium® or Diazepam 379 435 21 22 69 74 375 424
Atarax® 27 54 4 5 7 13 26 53
BuSpar® 71 81 6 6 23 21 63 78
Equanil® 40 18 2 4 3 9 40 15
Flexeril® 147 184 11 7 38 38 141 182
Librium® 84 111 3 4 11 14 83 110
Limbitrol® 19 17 3 4 6 9 18 13
Meprobamate 21 43 7 5 8 10 18 42
Miltown® 23 55 3 3 3 10 22 54
Rohypnol® 46 52 9 8 12 16 43 49
Serax® 16 16 2 4 7 11 14 10
Soma® 160 201 14 11 52 51 150 190
Tranxene® 48 38 3 2 10 10 47 37
Vistaril® 45 48 6 5 10 14 43 45
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 479 533 36 37 101 107 469 510
Meprobamate Products3 50 61 7 6 8 12 49 59
Muscle Relaxants4 198 249 15 12 57 58 189 239
130329
Table 1.90D – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Standard Errors of Percentages, 2011 and 2012
Tranquilizer Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Klonopin® or Clonazepam 0.09 0.09 0.08 0.07 0.19 0.19 0.11 0.11
Xanax®, Alprazolam, Ativan®, or Lorazepam 0.14 0.16 0.12 0.13 0.28 0.30 0.18 0.20
Valium® or Diazepam 0.15 0.17 0.08 0.09 0.20 0.21 0.19 0.21
Atarax® 0.01 0.02 0.02 0.02 0.02 0.04 0.01 0.03
BuSpar® 0.03 0.03 0.02 0.02 0.07 0.06 0.03 0.04
Equanil® 0.02 0.01 0.01 0.02 0.01 0.03 0.02 0.01
Flexeril® 0.06 0.07 0.04 0.03 0.11 0.11 0.07 0.09
Librium® 0.03 0.04 0.01 0.02 0.03 0.04 0.04 0.05
Limbitrol® 0.01 0.01 0.01 0.02 0.02 0.03 0.01 0.01
Meprobamate 0.01 0.02 0.03 0.02 0.02 0.03 0.01 0.02
Miltown® 0.01 0.02 0.01 0.01 0.01 0.03 0.01 0.03
Rohypnol® 0.02 0.02 0.04 0.03 0.04 0.05 0.02 0.02
Serax® 0.01 0.01 0.01 0.02 0.02 0.03 0.01 0.00
Soma® 0.06 0.08 0.05 0.04 0.15 0.15 0.08 0.09
Tranxene® 0.02 0.01 0.01 0.01 0.03 0.03 0.02 0.02
Vistaril® 0.02 0.02 0.02 0.02 0.03 0.04 0.02 0.02
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 0.19 0.21 0.14 0.15 0.29 0.31 0.24 0.25
Meprobamate Products3 0.02 0.02 0.03 0.02 0.02 0.04 0.02 0.03
Muscle Relaxants4 0.08 0.10 0.06 0.05 0.17 0.17 0.10 0.12
130329
Table 1.90P – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Tranquilizer Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Klonopin® or Clonazepam 0.0423   0.7880   0.0987   0.1035  
Xanax®, Alprazolam, Ativan®, or Lorazepam 0.0010   0.9164   0.2526   0.0015  
Valium® or Diazepam 0.6246   0.6928   0.8529   0.6231  
Atarax® 0.0801   0.6254   0.1440   0.1724  
BuSpar® 0.7816   0.5950   0.3254   0.5242  
Equanil® 0.7818   0.2945   0.1472   0.4836  
Flexeril® 0.0039   0.0778   0.4635   0.0013  
Librium® 0.1754   0.4570   0.6975   0.1987  
Limbitrol® 0.7563   0.4261   0.3447   0.7493  
Meprobamate 0.2680   0.2943   0.6026   0.2251  
Miltown® 0.0407   0.9415   0.0747   0.0778  
Rohypnol® 0.5832   0.6874   0.8624   0.4703  
Serax® 0.8904   0.2846   0.6570   0.6529  
Soma® 0.0171   0.2519   0.2624   0.0032  
Tranxene® 0.6396   0.9167   0.7391   0.6908  
Vistaril® 0.9135   0.4791   0.1903   0.8718  
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 0.0352   0.8101   0.1301   0.0696  
Meprobamate Products3 0.2203   0.4800   0.2279   0.2667  
Muscle Relaxants4 0.0058   0.1108   0.3482   0.0014  
130329
Table 1.91C – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Standard Errors of Numbers in Thousands, 2011 and 2012
Stimulant Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methamphetamine, Desoxyn®, or Methedrine1 410 426 21 15 56 62 404 418
Prescription Diet Pills2 282 343 14 14 39 45 276 338
Ritalin® or Methylphenidate 203 239 20 21 68 72 189 219
Cylert® 37 33 3 3 10 8 36 32
Dexedrine® 177 172 4 5 15 17 175 171
Dextroamphetamine 95 93 7 5 21 23 92 90
Didrex® 36 31 2 2 9 4 34 30
Eskatrol® 22 61 4 2 3 6 22 61
Ionamin® 60 95 2 2 8 2 59 95
Mazanor® 17 13 2 5 3 7 17 10
Obedrin-LA® * 11 6 4 * * * 10
Plegine® 12 13 * 2 3 6 11 12
Preludin® 63 70 2 4 9 8 62 70
Sanorex® 24 12 2 6 6 3 23 10
Tenuate® 44 52 3 1 4 4 44 52
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 310 379 19 21 59 67 300 367
Mazindol Products5 28 18 3 7 6 7 27 15
Methylphenidate or Dexmethylphenidate Products6 203 239 20 21 68 73 189 220
130329
Table 1.91D – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Standard Errors of Percentages, 2011 and 2012
Stimulant Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methamphetamine, Desoxyn®, or Methedrine1 0.16 0.16 0.08 0.06 0.16 0.18 0.20 0.21
Prescription Diet Pills2 0.11 0.13 0.06 0.06 0.11 0.13 0.14 0.17
Ritalin® or Methylphenidate 0.08 0.09 0.08 0.08 0.20 0.21 0.10 0.11
Cylert® 0.01 0.01 0.01 0.01 0.03 0.02 0.02 0.02
Dexedrine® 0.07 0.07 0.01 0.02 0.04 0.05 0.09 0.09
Dextroamphetamine 0.04 0.04 0.03 0.02 0.06 0.07 0.05 0.04
Didrex® 0.01 0.01 0.01 0.01 0.03 0.01 0.02 0.02
Eskatrol® 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.03
Ionamin® 0.02 0.04 0.01 0.01 0.02 0.00 0.03 0.05
Mazanor® 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.01
Obedrin-LA® * 0.00 0.02 0.01 * * * 0.00
Plegine® 0.00 0.01 * 0.01 0.01 0.02 0.01 0.01
Preludin® 0.02 0.03 0.01 0.01 0.03 0.02 0.03 0.03
Sanorex® 0.01 0.00 0.01 0.02 0.02 0.01 0.01 0.01
Tenuate® 0.02 0.02 0.01 0.00 0.01 0.01 0.02 0.03
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 0.12 0.15 0.08 0.08 0.17 0.19 0.15 0.18
Mazindol Products5 0.01 0.01 0.01 0.03 0.02 0.02 0.01 0.01
Methylphenidate or Dexmethylphenidate Products6 0.08 0.09 0.08 0.09 0.20 0.21 0.10 0.11
130329
Table 1.91P – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Stimulant Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methamphetamine, Desoxyn®, or Methedrine1 0.7062   0.1198   0.3871   0.5799  
Prescription Diet Pills2 0.1784   0.4866   0.0159   0.3207  
Ritalin® or Methylphenidate 0.0006   0.9266   0.3787   0.0008  
Cylert® 0.7700   0.9609   0.3240   0.9549  
Dexedrine® 0.3627   0.4712   0.9403   0.3487  
Dextroamphetamine 0.8308   0.2429   0.3907   0.9299  
Didrex® 0.4245   0.4271   0.2121   0.6102  
Eskatrol® 0.1010   0.7654   0.2534   0.1284  
Ionamin® 0.7377   0.8625   0.2061   0.7996  
Mazanor® 0.6497   0.1851   0.6314   0.3095  
Obedrin-LA® *   0.7683   *   *  
Plegine® 0.5991   *   0.7161   0.8911  
Preludin® 0.7361   0.4743   0.8220   0.7413  
Sanorex® 0.1446   0.0849   0.1934   0.1090  
Tenuate® 0.4000   0.2444   0.5800   0.4027  
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 0.2827   0.2427   0.0181   0.5567  
Mazindol Products5 0.2236   0.0453   0.7053   0.0938  
Methylphenidate or Dexmethylphenidate Products6 0.0005   0.8192   0.2830   0.0007  
130329
Table 1.92C – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Standard Errors of Numbers in Thousands, 2011 and 2012
Sedative Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methaqualone, Sopor®, or Quaalude® 314 325 5 6 14 12 311 325
Barbiturates1 190 225 7 6 8 9 189 224
Restoril® or Temazepam 112 166 7 10 17 22 110 165
Amytal® 67 36 3 4 8 4 67 35
Butisol® 24 90 4 3 8 6 22 89
Chloral Hydrate 54 35 2 3 3 6 54 35
Dalmane® 75 48 4 3 3 9 75 47
Halcion® 62 84 5 4 6 7 62 84
Phenobarbital 101 117 5 6 7 8 100 117
Placidyl® 93 132 1 2 * 2 93 132
Tuinal® 107 112 1 2 * 4 107 111
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 138 189 9 11 17 23 137 186
Any Barbiturates4 204 239 10 10 15 13 203 238
130329
Table 1.92D – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Standard Errors of Percentages, 2011 and 2012
Sedative Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methaqualone, Sopor®, or Quaalude® 0.12 0.12 0.02 0.03 0.04 0.03 0.16 0.16
Barbiturates1 0.07 0.09 0.03 0.02 0.02 0.03 0.10 0.11
Restoril® or Temazepam 0.04 0.06 0.03 0.04 0.05 0.06 0.06 0.08
Amytal® 0.03 0.01 0.01 0.01 0.02 0.01 0.03 0.02
Butisol® 0.01 0.03 0.02 0.01 0.02 0.02 0.01 0.04
Chloral Hydrate 0.02 0.01 0.01 0.01 0.01 0.02 0.03 0.02
Dalmane® 0.03 0.02 0.01 0.01 0.01 0.02 0.04 0.02
Halcion® 0.02 0.03 0.02 0.01 0.02 0.02 0.03 0.04
Phenobarbital 0.04 0.05 0.02 0.03 0.02 0.02 0.05 0.06
Placidyl® 0.04 0.05 0.00 0.01 * 0.01 0.05 0.07
Tuinal® 0.04 0.04 0.01 0.01 * 0.01 0.05 0.06
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 0.05 0.07 0.03 0.04 0.05 0.07 0.07 0.09
Any Barbiturates4 0.08 0.09 0.04 0.04 0.04 0.04 0.10 0.12
130329
Table 1.92P – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: P Values from Tests of Differences of Percentages, 2012 Versus 2011
Sedative Total
(2011)
Total
(2012)
Aged 12-17
(2011)
Aged 12-17
(2012)
Aged 18-25
(2011)
Aged 18-25
(2012)
Aged 26+
(2011)
Aged 26+
(2012)
*Low precision; no estimate reported.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methaqualone, Sopor®, or Quaalude® 0.8034   0.3264   0.0270   0.8491  
Barbiturates1 0.9854   0.7567   0.7171   0.9812  
Restoril® or Temazepam 0.0336   0.0265   0.3818   0.0599  
Amytal® 0.0432   0.5615   0.4230   0.0490  
Butisol® 0.3255   0.6341   0.7030   0.2917  
Chloral Hydrate 0.6363   0.7752   0.1226   0.5190  
Dalmane® 0.0457   0.4281   0.1500   0.0275  
Halcion® 0.2747   0.4289   0.6279   0.2740  
Phenobarbital 0.6198   0.5308   0.9954   0.6481  
Placidyl® 0.4175   0.3389   *   0.4479  
Tuinal® 0.8903   0.6093   *   0.9410  
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 0.0740   0.1083   0.2717   0.1179  
Any Barbiturates4 0.9158   0.3836   0.6101   0.9268  

Go to Top of PageGo to the Table of Contents